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ABSTRACT 
Huamin Hu: Design of Biomimetically Inspired Hydroxyapatite-Gelatin Based 
Composite for Bone Scaffold Application 
(Under the direction of Wei You) 
 
Bone tissue engineering (BTE) requires a sturdy biomimetic scaffold for restoration of 
large bone defects. This dissertation describes the progress made in improving our previously 
developed Gemosil composite consisting of Hydroxyapatite-Gelatin (HAp-Gel) with silane 
cross-linker as a potential scaffold. Our initial goal was to further improve the mechanical 
strength of the composite. We first successfully doubled the mechanical strength of the 
composite through adding selected co-solvent during the sol-gel process. We further 
experimentally confirmed that the improvement of the mechanical strength is due to the 
improved morphology of both the silane network and the Gemosil composite. Unfortunately, the 
scaffold fabricated from this composite (even with the newly optimized processing condition) 
underwent rapid degradation in water, and rapidly lost its mechanical strength.  
To mitigate this degradation issue, we attempted to incorporate a cross-linkable polymer 
into the Gemosil composite, aiming to further increase mechanical strength of the Gemosil 
composite with an additional polymeric network (i.e., reinforcing network). Specifically, we 
synthesized a new biocompatible and biodegradable copolymer, poly(L-lactide-co-propargyl 
carbonate) with pendent catechol functional groups. These catechol functional groups served as 
“liaison” molecules to help to improve the interfacial adhesion between the polymer network and 
the various components of the Gemosil. We demonstrated that through incorporating this
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copolymer together with mussel-inspired dopamine into Gemosil system, the compressive 
strength of the scaffold could be improved by 20% under aqueous condition. 
Finally, despite the impressive adhesive and coating property of dopamine/polydopamine 
demonstrated by us and others, polydopamine (PDA) has its own limitations. For instance, 
PDA’s black color is not favored for clinical applications and its polymerization mechanism is 
still elusive. We synthesized a series of dopamine analogues with different alkyl chain lengths 
between the catechol and the amine. We found all of these new dopamine analogues were able to 
polymerize. Through studying the adhesive and coating ability of these new dopamine 
analogues, together with systems having catechol and selected alkyl amines (unbound to 
catechol), we showed that the covalent linkage between the catechol and the amine via an alkyl 
chain is not required to show the adhesive property; however, this covalent link is crucial to 
achieve the impressive coating property of dopamine and its analogs. Our findings offer new 
insights in designing mussel-inspired materials for future BTE application, and further 
mechanistic understanding of the polymerization of dopamine and these new dopamine 
analogues.  
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Chapter 1 INTRODUCTION TO BONE TISSUE ENGINEERING 
1.1 Needs for Developing Bone Repair Methods 
Bone is a rigid organ in our body, which has many important physiological functions. 
First, it provides a rigid skeletal framework, which supports and protects other body tissues. 
Second, it can form a system of rigid levers, which allow body to move with attached muscles. 
However, large bone defects, which can’t heal by bone self-repair mechanisms alone, frequently 
occur due to injuries, diseases and aging.1 It has been reported that the total number of bone 
surgeries has increased from 700,000 in 1998 to over 1.1 million in 2005 in the US alone,2 
accompanied with the rapidly increase in medical expenses. The prevalence of bone defects 
highlights the needs for exploring effective and affordable bone treatments. 
1.2 Characteristics of Bone 
To find an ideal treatment for large bone defects, it is necessary to understand the 
chemical composition, structure and biology of natural bone. Macroscopically, bone consists of 
two types of tissues, cortical bone (dense out shell) which is mainly responsible for mechanical 
support, and cancellous bone (inner porous core) which provides space for nutrition exchange 
and metabolic activities.3 Despite differences in the macro-scale structure of these two tissues, 
they have similar chemical compositions. It was found that bone is actually a composite material 
with two main components. One is a strong and brittle inorganic component (mainly 
hydroxyapatite (HAp), Ca10(PO4)6(OH)2), which gives bone strength. The other is a soft and 
flexible organic component (mainly protein collagen), which endows bone with toughness.4 
However, HAp and collagen are not just physically blended with each other in natural bone. It 
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has been demonstrated that cortical bone consists of a hierarchical structure in which HAp and 
collagen are highly organized at different length scales.5 As shown in Figure 1.1, at nanoscale, 
HAp and collagen are presented in the form of mineralized collagen fibril, in which HAp 
nucleates along collagen fibers.6,7 This mineralized collagen fibril will function as the “building 
block” to further form different microarchitecture in bone, such as extrafibrillar matrix, lamellae 
and finally osteons.8 The composite nature and the complex hierarchical structure of cortical 
bone explain why bone has such impressive mechanical properties.9,10 It has been reported that 
the compressive strength of cortical bone is around 200 MPa.11 In contrast, due to the porous 
macrostructure and irregular microstructure of cancellous bone,12 it demonstrates a much lower 
compressive strength compared to cortical bone, ranges from 1-13 MPa.13 
 
 
Figure 1.1. Hierarchical structure of human cortical bone. (Reprinted from reference 7b with 
permission. Copyright nature publishing group) 
Furthermore, bone has been regarded as a “smart material” due to its self-repair ability 
when the damage is small.14 The self-repair ability is realized by a process known as bone 
remodeling, during which older or damaged bone is gradually replaced by new bone cells.3 
Figure 1.2 has shown a simplified bone remodeling cycle with three major stages: starting with 
bone resorption which is accomplished with osteoclasts, followed by a reversal/transition period 
and finally new bone formation through osteoblasts.15 Additionally, it has been recognized that 
3 
 
bone remodeling follows “Wolff’s Law”, which states that bone will accommodate itself to 
become denser/looser to the change of external load.16 In summary, considering the complexity 
of natural bone, it is a grand challenge to find a treatment for large bone defects, which could 
structurally, mechanically and functionally replicate our natural bone.  
 
Figure 1.2. Bone remodeling process for bone self-repair. (Reprinted from 
https://www.york.ac.uk/res/bonefromblood/background/boneremodelling.html. Copyright by 
Biomedical Tissue Research, University of York. Reprinted with permission) 
1.3 Current Treatments and Emerging Bone Tissue Engineering Field 
To date, the majority of treatments for large bone defects have focused on developing 
bone graft to fill bone defects and stimulating new bone formation. Despite the fact that various 
bone grafts have been developed, they all have significant drawbacks. Autograft, which involves 
the use of host bone (usually from the pelvis iliac crest of the patient) to fill bone defect, has 
been regarded as the gold standard for bone grafts.17 However, its clinical application has been 
greatly impeded due to the limited supply and risk of donor site morbidity.18 To mitigate this 
issue, allograft19 and xenograft,20 which replace patients own bone tissue with bone tissue from 
other humans and non-humans, respectively, have been actively explored for bone treatment. 
Nevertheless, they are now considered to be inappropriate for bone treatment due to the risk of 
infection, disease transmission and most importantly, host immune rejection.21-24  
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Considering the pitfalls in using natural bone grafts (i.e. autograft, allograft and xenograft) 
discussed above, synthetic biomaterials with good biocompatibility and mechanical properties 
have been extensively investigated as an alternative bone substitutes for treatment. These 
synthetic alternatives have demonstrated several advantages over natural bone grafts, such as 
availability, reduced infection, and mitigated host rejection.25 Initial attempts were focused on 
the utilization of inert, nonporous materials with physical properties (such as mechanical strength) 
similar to natural bone to permanently undertake the function of damaged bone. Implants 
including metals (such as stainless steel, titanium, and alloys),26 ceramics (such as alumina-
oxide),27 and polymers (such as polymethylmethacrylate)28 have become the well-established 
bone grafts for decades.29 However, the inert property of such materials will cause a non-specific 
immune response from our body, which results in the formation of a soft fibrous tissue at the 
biomaterial-tissue interface.30 This indirect contact between the implant and the bone would 
likely induce mechanical instability and dislocation over time. To overcome this problem, 
materials with bioactive surfaces were developed to promote bone formation at the material-bone 
interface, thereby inducing a stronger bonding between the bone and the implant. This bioactive 
surface can be easily obtained through coating material with bioactive ceramics such as HAp, 
bioactive glass, and β-tricalcium phosphate.31 While there has been significant progress in 
developing synthetic bone grafts, there are still challenges to be addressed. For example, the 
mismatch of mechanical strength between synthetic bone grafts and natural bone often results in 
stress-shielding to surrounding bone32 and fatigue failure of the implant under cyclic loading.33  
Recently, bone tissue engineering (BTE) has emerged as a promising approach to 
overcome these aforementioned issues. The fundamental concept behind BTE is to utilize a 
temporary three-dimensional (3D) porous scaffold at the bone defect site, which will provide 
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microenvironment for cell transplantation and proliferation. As the new bone starts to regenerate, 
the 3D scaffold will gradually degrade in vivo. Eventually, the synthetic scaffold will be totally 
replaced by the newly regenerated bone (Figure 1.3).34 It is envisioned that BTE will avoid the 
disadvantages of current treatments and be the ideal treatment for bone defects in the near future.  
 
Figure 1.3. Bone tissue engineering concept. (Reprinted from https://goo.gl/images/CtzKJF. 
Reprinted with permission) 
1.4 Bone Tissue Engineering: General Principles and Challenges 
As shown in Figure 1.4, BTE relies on three main components: (1) a temporary 3D 
porous scaffold made from natural and/or synthetic degradable biomaterials to provide 
mechanical support and proper environment for bone regeneration; (2) biochemical factors such 
as signals and growth factors to induce cells to the implant site and promote cells to regenerate 
new bone tissue; and (3) cells (usually stem cells) to produce bone matrix.35 Typically, the BTE 
surgical procedure starts with obtaining cells from patients, followed by seeds cells to scaffold to 
allow the production of extracellular matrix (ECM) inside the scaffold in vitro, and finally 
implants the scaffold with ECM at bone defect site in patients.36 After years of efforts, it was 
found that each of the individual components presents its unique challenges.  
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Figure 1.4. The paradigm of bone tissue engineering. (Reprinted from reference 27 with 
permission. Copyright Royal Society of Chemistry) 
Cells: Until now, multiple cell sources have been explored for BTE application. To name 
a few, bone marrow aspirates,37 bone marrow mesenchymal stem cells,38 embryonic stem cells, 
etc.39 Among these, mesenchymal stem cells (MSCs) obtained from bone marrow have been 
widely studied due to their capability to differentiate into various tissues, including bone. 
Moreover, from a technical perspective, it’s relatively easy to collect MSCs from bone marrow. 
Preliminary clinical trials have indicated that implanted scaffolds seeded with MSCs promote 
faster bone tissue regeneration compared to scaffolds without cells.40 Nevertheless, in many 
cases, the number of collected stem cells is not sufficient for clinical application. As a result, the 
biggest challenge is to increase the number of MSCs. In practice, we can expand the MSCs by 
cell culture in vitro, however, this process not only increases the surgery time and cost but also 
demonstrates complexity. For instance, it has been observed that stem cells will gradually lose 
their proliferation and differentiation ability during expanding (i.e., increase the number of 
MSCs) in vitro.41,42  
3D porous scaffold: The scaffold has been regarded as a crucial component for BTE 
since it provides the mechanical support for cell growth and following bone regeneration 
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process. There are several key considerations in designing a scaffold, including biocompatibility, 
biodegradability, proper mechanical properties, scaffold architecture, fabrication technique, 
among others.43 A detailed review of scaffold design rules is provided in the following section.  
Biochemical factors: Proteins that play a key role in cell proliferation and differentiation 
are called biochemical factors.44 Recently, various studies have been focused on exploring bone-
related growth factors and applied them to BTE. It’s generally agreed that growth factors would 
stimulate cell growth in bone scaffold.2 For instance, bone morphogenetic protein (BMP)45 (a 
type of growth factor) alone (i.e. without scaffold and cells) can induce bone regeneration, which 
indicates their impressive capability in promoting cell growth. However, the biggest challenge in 
utilizing growth factors is targeted delivery to the repair site. Currently, various carriers for 
growth factors have been examined, such as hydrogels and stimuli-responsive polymers.46 
Unfortunately, they could not afford a steady, controllable and sustained release profile.42 
Another significant challenge is the identification of the effective dose of growth factors for bone 
regeneration, preferably with minimal/tolerable side effects, which needs further study.47 
1.5 Bone Scaffold Design Rules 
Based on the discussions above, an ideal scaffold is essential for successful BTE 
applications. In principle, the scaffold should allow and/or promote cell attachment, 
proliferation, and differentiation, and most importantly, provide sufficient strength for load 
bearing. As a result, an ideal scaffold should satisfy following requirements: biocompatibility, 
good mechanical properties, proper pore size, bioresorbability, growth factor delivery, and easy 
fabrication.  
Good biocompatibility: First, the scaffold needs to ensure all normal cell activities during 
bone regeneration, and secondly, the scaffold should not cause any side/toxic effects to the 
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body.48 More recently, “osteoinductive biomaterials” have been demonstrated to have great 
promise for BTE due to their ability to stimulate MSCs to develop into preosteoblasts, which will 
promote bone regeneration.49  
Good mechanical properties: Ideally, the scaffold should have mechanical strength 
comparable to natural bone in the implanted site, which helps load transfer during bone 
regeneration process.50,51  
Proper pore size: The scaffold should possess a minimal pore size of 50 μm for effective 
cell seeding. Larger pores are preferred as they provide better cell seeding and essential nutrients 
exchange for cell survival. Recently, research has suggested that the scaffold should have inter-
connected pore structure with pore size ranging from 200-350 μm.52 Moreover, it was 
demonstrated that the combination of micro and macro pores would enhances bone 
regeneration.53 It should be mentioned that the scaffold porosity is also closely related to its 
mechanical strength and is largely determined by the fabrication technique.54 As a consequence, 
designing the porosity of scaffold should also consider the balance of these factors.  
Bioresorbability: An ideal scaffold should be able to degrade with time in vivo, 
preferably at a controlled resorption rate, produce non-toxic degradation products and create 
space for the new bone gradually. The degradation behavior of scaffold should vary based on the 
targeted application.55  
Growth factor delivery: As discussed in section 1.4, the effective incorporation of growth 
factor can promote cell growth and enhance bone regeneration.  
Easy fabrication: Conventional techniques for fabricating scaffolds include solvent 
casting, freeze-drying, thermally induced phase separation, gas forming, sol-gel, and 
electrospinning. However, it is generally difficult with any of these methods to control pore size 
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and porosity, which influence bone regeneration.56 Recently, 3D-printing together with 
computational topology design (CTD) has been demonstrated as a powerful way to fabricate 
scaffold with controlled pore size and porosity.57 
1.6 Current Materials Options and Limitations 
Until now, various materials have been explored as BTE scaffolds. As shown in Table 
1.1, these systems include biodegradable polymers, ceramics, and composites.58,59 Generally, 
these material systems have acceptable biocompatibility and produce nontoxic degradation 
products; however, none of them can meet the entire set of criterion discussed in Section 1.5. 
There are limitations with each material system, as discussed below.  
Biodegradable polymers: Various polymers - either from natural origin (collagen (Col), 
gelatin (Gel), alginate, chitin, etc.)60,61 or synthetic origin (polycaprolactone (PCL), polylactic 
acids (PLA), poly(glycolic acid) (PGA), etc.)62 - have been explored for bone scaffold 
application.63 The main drawbacks for these polymers are their low mechanical strength (i.e. they 
cannot sustain stress loading in the implanted site over a long period of time) and poor 
formability. Moreover, the degradation rate of these polymers is too fast for bone regeneration 
(i.e. materials erode in body fluid at a fast rate, leading to a quick loss of massive amount of 
materials), which results in low bulk corrosion resistance.64 Thus, for synthetic polymers to be a 
viable option for BTE, it needs to display a more controllable degradation rate, tunable 
mechanical properties and can be prepared with easy fabrication techniques. Finally, it is also 
desirable to design polymers that can improve cell attachment and demonstrate potential to 
deliver growth factors.  
Bioactive ceramics: These can be from either natural or synthetic in origin such as HAp, 
calcium phosphate, bioactive glass and calcium silicate. Due to the chemical similarity between 
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ceramics and our natural bone, they have shown high compressive strength, providing high 
resistance to deformation.65 Another advantage of ceramics is that they can be easily fabricated 
into scaffold. Nevertheless, the utilization of ceramics is impeded by two reasons. First, they 
only show relatively slow degradation, which is not favored for BTE. Second, ceramics are often 
brittle, which would likely to cause fracture after implantation.  
Composite: The composite systems, consisting of two or more materials, have emerged 
with the hope to incorporate strength from each material to this complex system.58,59 In general, 
there are three types of combinations, namely co-polymers, polymer-polymer blends, and 
polymer-ceramic composites. For instance, poly(lactic-co-glycolic acid) (PLGA) is a copolymer 
of polylactide and polyglycolide, which has been regarded as a promising option for BTE 
application due to its biodegradability and ease of fabrication. Moreover, to address necrosis, 
caused by the acidic degradation product of PLGA, polyphosphazenes have been blended with 
PLGA to neutralize the acidic degradation product by releasing only neutral or basic products.66 
Recently, polymer-ceramic composites combining the advantages of polymers and ceramics 
have emerged as the most promising option for scaffold since they have shown tunable 
mechanical strength, adjustable degradation rate and good biocompatibility. In fact, bone itself is 
a polymer-ceramic composite material, consisting of biopolymer collagen and bioceramic HAp, 
thus bone is strong but also tough. In spite of these advantages of composite materials, their 
development is rather slow, due to processing constraints and the formation of undesired 
microstructures in these composites. Thus, significant efforts are still warranted in pursuit of 
ideal materials for bone scaffold.67  
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Table 1.1. Current material options and related properties 
 Polymers Bioceramics Composites 
Compressive strength Poor 
(2-40MPa) 
Good 
(50-400MPa) 
Fair 
(60-150 MPa) 
Degradation Very Fast 
(2-12 mo.) 
Slow Tunable 
Formability Poor Good Tunable 
Examples Collagen (COL) 
Gelatin (GEL) 
Alginate, Chitin  
PCL, PLA, PGA 
Hydroxyapatite (HAp) 
Bioactive glass 
Tricalcium phosphate 
Calcium silicate 
HAp-Gel 
HAp-Col 
PLGA 
1.7 Biomimetic Hydroxyapatite-Gelatin Composite Materials 
For all these reasons, the You group in Chemistry and the Ko group in the Dental School 
have formed a strong collaboration to explore and develop polymer-ceramic composite-based 
materials for bone scaffolds. Specifically, we focused on mimicking natural bone since natural 
bone is perfect. In this decade long collaboration, we have developed several generations of 
biomimetic composites as shown in Figure 1.5.  
HAp-Gel: We first developed a nanocomposite named HAp-Gel, mimicking 
hydroxyapatite-collagen (HAp-Col) in nature bone (i.e., gelatin (Gel) is denatured collagen 
(Col), mimicking the function of Col in nature bone). HAp-Gel was prepared by co-precipitation 
of calcium hydroxide (Ca(OH)2) with phosphoric acid in the presence of gelatin. Similar to the 
interaction between various components in natural bone, HAp-Gel showed chemical bond 
formation between calcium cations of HAp nanocrystals and carboxyl anions of gelatin 
macromolecules. Furthermore, HAp-Gel has a self-organized structure along c-axis of 
crystalline of HAp nanocrystals, which would account for the improved mechanical 
strength of this composite.68 However, HAp-Gel is a particulate powder and hard to form the 
scaffold.  
Gemosil: To address the issue with formability, the Ko group used an aminosilane (bis[3-
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(trimethoxysilyl) propyl] ethylenediamine (enTMOS)) as the chemical linker to facilitate the 
binding and solidification of HAp-Gel, and named the composite Gemosil (i.e., silane-modified 
HAp-Gel composite).69 Compared to previously developed glutaraldehyde linker treated HAp-
Gel,70 this new composite, Gemosil, demonstrated increased compressive strength and good cell 
compatibility. Still, the compressive strength of Gemosil was only ~40% of the value achieved 
by cortical bone (80 MPa vs 205 MPa11). The biaxial flexural strength of Gemosil was merely 
~18% of that achieved by the cortical bone (40 MPa vs 220 MPa71). 
Gemosil-Poly: To further improve the mechanical strength of Gemosil, we have 
attempted to incorporate biocompatible polymers. For example, we designed a silane-
functionalized poly(L-lactide-co-propargyl carbonate) (P(LLA-co-PC)) copolymer, which was 
blended into the Gemosil composite, aiming to enhance the long-range interactions among 
different components within the Gemosil composite. We named this new composite as Gemosil-
Poly.72 However, this polymer-enriched composite only improved the biaxial flexural strength 
from 40 MPa to 60 MPa, still much lower than that of the natural bone. This limited 
improvement was attributed to the poor solubility of polymer in the processing solvent MeOH, 
resulting in an inhomogeneous mixing of polymer with other components in the system and 
weak adhesion among different components. 
Gemussel: Most recently, we introduced polydopamine (PDA) – a mussel adhesive 
protein inspired material that has shown excellent coating and adhesion properties – into 
Gemosil, aiming to improve the adhesion between the hydrophilic HAp-Gel and the hydrophobic 
siloxane matrix and named this latest generation of composite as Gemussel. However, the 
compressive strength improvement was still limited, only from 80 MPa to 120 MPa.73 This 
caused by the lower molecular weight of PDA, which likely failed to reproduce the long-range 
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interaction of collagen in natural bone.  
Thus, the aim of this dissertation is to further improve properties of HAp-Gel-based 
composite to make it a better material for scaffold for BTE application.  
 
Figure 1.5. The evolution of different generations of HAp-Gel based composites. 
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Chapter 2 DRAMATIC IMPROVEMENT OF MECHANICAL STRENGTH OF 
SILANE-MODIFIED HYDROXYAPATITE-GELATIN COMPOSITES VIA 
PROCESSING WITH CO-SOLVENT 
2.1 Introduction  
While substantial improvements have been made in improving the mechanical strength of 
HAp-Gel based composites, the resulting composites still do not meet the requirements for BTE 
application. The limited improvement of composite mechanical strength with biocompatible 
polymer or polydopamine (PDA) made us speculate that the main reason for the poor mechanical 
strength of Gemosil (i.e. silane-modified HAp-Gel) might be the intrinsically weak silane 
network in this composite. Given that silane matrix is the major component of Gemosil 
composite (~ 46% by weight), engineering the silane network to dramatically improve its 
mechanical strength would be an alternative– perhaps an ideal – solution. 1 
It has been well established that the silane network formation is a sol-gel process. This 
process starts with hydrolysis of alkoxide silane precursors to form silanol, followed by the 
condensation/polymerization between the silanol groups to form siloxane (Si-O-Si) linkages.74 
The gel structure (e.g., morphology and porosity), which decides the mechanical strength of as 
formed sliane network, can be significantly influenced by the processing method and specific 
conditions, including pH, R ratio (R=[H2O]/alkoxide precursor),75 solvents76,77 and dry process.74 
As a result, to produce a gel with desirable properties, the processing method and conditions 
need to be carefully optimized. Processing conditions become even more important when 
                                                 
This chapter previously appeared as an article in ACS Omega. Reprinted with permission from H. Hu, B. W. Huang, 
Y. T. Lee, J. Hu, S. W. Wong, C. C. Ko, and W. You, ACS Omega, 2018, 3(3), pp 3592-3598. Copyright (2018) 
American Chemical Society.  
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preparing composite materials that contain the silane network. For instance, an inhomogeneous 
mixing of different components in the composite can induce fractures during drying,74 which can 
significantly decrease the final mechanical strength of such composites.  
Among the aforementioned factors that could influence the gel structure, controlling the 
drying process of the sol to gel formation has been shown to have a crucial impact on the 
mechanical property of the final composite.74 To improve the ease of drying while minimizing 
cracking, co-solvents78,79 have often been employed. Moreover, different co-solvents exert 
different control on the kinetics of hydrolysis and condensation, resulting in the formation of 
sliane network with different structures (Scheme 2.1) and different physical properties.76,77 All 
these inspired us to explore a variety of co-solvents to further improve the mechanical properties 
of our Gemosil. Indeed, we find that by choosing the appropriate co-solvent, the mechanical 
strength of Gemosil can be greatly improved. Compared with the original Gemosil, the new 
Gemosil composite – processed with tetrahydrofuran (THF) as the co-solvent – demonstrated 
almost twice the mechanical strength as much as the original composite without THF (i.e., 
compressive strength: 97 MPa vs 195 MPa, biaxial flexural strength: 222 MPa vs 431 MPa). 
Furthermore, we show that the improvement of mechanical strength is due to the improved 
morphology of sliane network and the uniform distribution of HAp-Gel in the enTMOS matrix. 
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Scheme 2.1. enTMOS network formed in different solvent system 
 
2.2 Co-Solvent Effect: Observation 
According to previous findings, on the one hand, low viscosity solvents promote rapid 
hydrolysis, which would likely resulted in condensed network caused by fast condensation 
reactions to occur (due to the increased concentration of reactants for condensation).76 On the 
other hand, non-polar aprotic solvent is preferred for a fast condensation reaction. This is 
because hydrogen bonding and/or electrostatic interactions between polar solvents and the 
nucleophilic substitution reaction intermediate will slow the rate of condensation.77 To form a 
dense silane network and thereby achieve higher mechanical strength of such a gel, one would 
need rapid hydrolysis and fast condensation reactions. Thus, non-polar aprotic solvent with low 
viscosity would be ideal. To experimentally verify this hypothesis, we chose a number of co-
solvents in this study (Table 2.1). These co-solvents have different viscosity values and can be 
categorized into three different groups (i.e., polar protic, polar aprotic and non-polar aprotic). 
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Table 2.1. Biaxial flexural strength of composite with different co-solvents 
Type of 
co-solvent 
Entry Co-solvent/MeOH 
(v/v=9:5) 
Viscosity of 
co-solvent 
b.p. of co-
solvent (°C) 
Biaxial flexural 
strength (MPa) 
Polar 
Protic 
1 MeOH 0.55 64.7 222.83±54.80 
2 EtOH/MeOH 1.07 78.37 102.32±34.53 
Polar 
aprotic 
3 CH3CN/MeOH 0.37 81.3 410.43±25.48 
4 DMSO/MeOH 1.99 189 138.01±19.40 
Non-polar 
aprotic 
5 THF/MeOH 0.46 66 431.35±58.72 
6 THP/MeOH 0.52 88 471.40±44.83 
7 Dioxane/MeOH 1.18 101.1 291.05±75.75 
8 DME/MeOH 1.1 85 408.73±51.38 
 
Our results in Table 2.1 clearly demonstrate that the co-solvents indeed have a 
strong influence on the biaxial flexural strength of the composite. First, as we expected, 
among the three types of co-solvents we studied, aprotic ones – with the exception of 
dimethyl sulfoxide (DMSO) – improve the mechanical strength of the composite more 
than protic ones. In some cases, we could even increase the mechanical strength over 100% 
when compared with that of the original Gemosil (prepared with MeOH only, entry 1 of 
Table 2.1). For instance, when using acetonitrile (CH3CN) and tetrahydrofuran (THF) as 
the co-solvents, the flexural strength of such composites increases from 222 MPa to 
around 410 MPa and 431 MPa, respectively (entry 3 and entry 5 in Table 2.1). This can 
be explained by the fact that THF and CH3CN are aprotic in nature, which can promote 
fast condensation reaction when compared with the protic ones (such as methanol (MeOH) 
and ethanol (EtOH)). Moreover, THF and CH3CN also have relative lower viscosity 
values, which would likely promote fast hydrolysis reaction of enTMOS. For these 
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reasons, the addition of THF or CH3CN would result in a dense silane network as shown 
in Scheme 2.1 with higher flexural strength. This can be further supported by the 
impressive improvement of compressive strength, which increases from 97 MPa when 
processed with pure MeOH to 195 MPa when adding THF as the co-solvents (Table A2.1, 
entry 2 and 4, Appendix). However, if all MeOH was replaced by THF (i.e., THF only) 
or CH3CN (i.e., CH3CN only), the sol-gel reaction would be completed too fast (gelation 
time was reduced to 2 min from the original 5 min). The too fast cure rate would result in 
the incomplete condensation reaction, evidenced by the opaque colour of pure enTMOS 
(Figure A2.5 (c) and (e) in Appendix), leading to lower mechanical strength of such a 
composite. For instance, the compressive strength and biaxial flexural strength of THF 
only composite would decrease from 195 MPa to 72 MPa and 430 MPa to 152 MPa, 
respectively (entry 4 and entry 5 in Table A2.1 in Appendix). Second, for co-solvents in 
the same category, the boiling point of the co-solvents also plays a role in the mechanical 
strength of the composite. For instance, composites made from dioxane/MeOH and 
dimethoxyethane (DME)/MeOH have different flexural strengths, 291 MPa vs. 408 MPa 
(Table 2.1, entry 7 and 8). It appears that a close match of the boiling point of co-solvent 
with that of MeOH (65 °C) would help the drying process. In this specific case, the 
boiling point of dioxane (101 °C) is too far from MeOH compared to the boiling point of 
DME (85 °C). This could be explained by that having a co-solvent with a similar boiling 
point to that of the primary solvent can lead to a more uniform solvent evaporation, which 
can help reduce the large cracks in the final composite and result in higher mechanical 
strength. Finally, viscosity of the co-solvent does not appear to have any correlation with 
the biaxial flexural strength of the final composite. This can be seen from cases of 
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CH3CN/MeOH, THF/MeOH, and DME/MeOH. A range of viscosity values (0.37, 0.52 
and 1.1) were observed, yet all co-solvents offered similarly high flexural strength of the 
final composites (over 400 MPa). 
2.3 Hypothesis for Co-solvent Effect 
We hypothesize that the effect of co-solvent on the mechanical strength of the Gemosil 
composite is mainly due to the combined effects from hydrolysis and condensation of silanes that 
changed the morphology of the composite, rather than from co-solvent induced chemical 
reaction/interaction between different components within the composite. Specifically, adding co-
solvent into the processing solvent (i.e., MeOH) can have two functions during the composite 
formation. First, mixing different co-solvents with MeOH increases the total volume of solvent 
when compared with the original processing method reported previously. The extra solvent 
would allow the various components, including HAp-Gel, Ca(OH)2 and enTMOS, to mix more 
homogenously. Second, the co-solvent can have a subtle impact on the morphology of the 
enTMOS network in the final composite (i.e., branched or condensed network, shown in Scheme 
2.1), likely caused by the different rates of hydrolysis and condensation when different co-
solvent is applied. As discussed earlier, the polarity and boiling point of the co-solvent can have 
a direct impact on these fundamental steps (i.e., hydrolysis and condensation) in the sol-gel 
process. Macroscopically, composites processed with an appropriate co-solvent show less 
cracks/holes, which would benefit a higher mechanical strength. Finally, since the solvent can be 
completely removed during the drying process, the biocompatibility of these composites can be 
maintained in addition to the improved mechanical strength. 
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2.4 FT-IR Study 
To experimentally verify the hypothesis, we first applied FT-IR spectroscopy to identify 
specific chemical bonds in the final gel structure and to monitor the sol-gel reaction process.80 
We started with pure enTMOS gels formed from different co-solvents/MeOH systems to probe 
whether the co-solvent reacted with enTMOS. Three representative co-solvents/MeOH systems 
from these three different types (Table 2.1) were selected, THF/MeOH, CH3CN/MeOH and 
MeOH only. First, the FT-IR of pure enTMOS network prepared with CH3CN/MeOH and 
THF/MeOH show characteristic peaks for enTMOS gels (e.g., Si-O-Si stretching at 1029 cm-1 
and 1118 cm-1), indicating the formation of aminosilica matrix. As expected, enTMOS gels made 
from different co-solvent/MeOH systems demonstrated almost identical absorption spectra (from 
4000 cm-1 – 400 cm-1) to that of the enTMOS gel made from MeOH only (Figure 2.1 (a)). This 
indicates that the co-solvents did not react with the enTMOS during the sol-gel process. 
Moreover, the almost identical absorbance of peaks corresponding to the Si-O-Si bond for 
enTMOS processed with different solvents indicates that the total amount of Si-O-Si bond is 
comparable across the samples. We also performed 29Si solid state NMR to further investigate 
the variety of Si bonds (e.g., Si-O-Si and Si-OH) that were involved in the sol-gel process. As 
shown in Figure A2.2 in Appendix, for all silane networks with different processing co-solvents, 
we observed two Si peaks. The signal at – 65 ppm is corresponding to the formation of Si-O-Si, 
whereas the other signal at – 58 ppm is attributed to the Si-OH structure from the incomplete 
condensation.81  Again, the 29Si NMR spectra are very similar across the samples, implying 
similar amount of Si species.  Second, in order to examine whether the co-solvents would react 
with other components in the Gemosil composite, i.e., HAp-Gel and Ca(OH)2 with 
chlorhexidine(CHX), we applied FT-IR to study the Gemosil composite. Again, these FT-IR 
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spectra of composites made from different co-solvents/MeOH systems are almost identical to 
each other (Figure 2.1 (b)), indicating that the co-solvents didn’t react with the remaining 
components (i.e., HAp-Gel and Ca(OH)2 with CHX) in the Gemosil system. Most importantly, 
we did not observe any co-solvents/MeOH characteristic absorption in all FT-IR spectra, 
indicating that solvent was completely removed after drying. This is ideal for BTE application 
since the residual co-solvent (if any) could be toxic. 
 
 
Figure 2.1. FT-IR spectra of (a) enTMOS gels and (b) Gemosil composites prepared from 
different solvent systems. 
2.5 Morphology Study 
Results from the FT-IR study rule out the possibility that the improvement of mechanical 
strength of these co-solvent-treated composites was from co-solvent-induced chemical 
interactions/reactions. Thus, it is very likely that the optimized morphology of the Gemosil 
composite is the main reason for the improved flexural strength. We next used SEM to 
investigate the morphology (i.e., phase distribution, porosity) of the composite formed from 
different co-solvent/MeOH systems and of the pure enTMOS network. We chose to study the 
cross-section of the composite made from two representative co-solvent/MeOH systems, namely, 
CH3CN/MeOH and THF/MeOH. Composites made from only MeOH or THF were also 
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investigated as the reference. From the cross-section images of these composites (Figure 2.2), 
one can clearly observe that composite formed from CH3CN/MeOH or THF/MeOH has a much 
smoother surface (less visual cracks), which agrees well with the greatly improved flexural 
strength of the composites (Table 2.1). In contrast, composite made from MeOH only has large 
cracks (Figure 2.2(a)). Furthermore, there are two distinct phases probed by EDS: one is 
enriched with HAp-Gel, while the other is enriched with silsesquioxane phase (Figure A2.3 in 
Appendix). Comparing the phase distribution in composites made from MeOH only or THF 
only with that in composites made from CH3CN/MeOH or THF/MeOH, the enTMOS phase and 
HAp-Gel distribute more homogenously with the addition of co-solvent (CH3CN or THF). We 
attribute this homogenous phase distribution to the increased total volume of solvent with the 
addition of co-solvent, which would help the homogenous mixing of different components.  
More importantly, these co-solvents can control the drying process of forming the 
Gemosil composite, since the mixed solvent (co-solvent+MeOH) would have a slower 
evaporation rate than that of the pure MeOH. If this were the case, a further deviation of the 
boiling point of co-solvent from that of the main solvent (i.e., MeOH) would have a more 
appreciable effect on the drying process and the morphology of as-formed composite. Indeed, the 
composite made from dioxane/MeOH (Figure A2.4 (c) in Appendix) shows larger cracks than 
the one made from THF/MeOH. This can be ascribed to the fact that the boiling point of dioxane 
(101 °C) is too far from that of MeOH than that of THF (66 °C).  
While our results show that mixing co-solvent into the main solvent can be beneficial to 
improving the morphology and mechanical strength of our composites, having pure co-solvent 
alone (i.e., co-solvent as the sole solvent) cannot offer the same improvement. This can be seen 
by comparing the composite made from co-solvent/MeOH with that made from THF only. The 
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composite made with THF only shows less homogeneity and weaker mechanical strength 
(Figure 2.2 (d) and entry 5 in Table A2.1 in Appendix). We speculate that a too fast gelation 
would occur when pure THF was used, which would lead to the inhomogeneous mixing of 
different components in the composite.  
Finally, we applied TEM to investigate more details about each component in the 
composite. In principle, if the co-solvents did not react with the HAp-Gel crystal, we should be 
able to observe intact HAp-Gel crystals. Indeed, TEM images of composites show the Hap-gel 
nanocrystals remain intact after the processing with co-solvents (Fig A2.6 in Appendix). This 
further proves that the improvement of mechanical strength by these co-solvents could be solely 
related to the optimized enTMOS matrix structure and the more homogenous mixing of different 
components in the composite.  
 
Figure 2.2. SEM images of composites made from (a) MeOH only; (b) CH3CN/MeOH; (c) 
THF/MeOH; (d) THF only. Inset: the physical appearance of the composite under that condition. 
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2.6 Biocompatibility Study 
Good biocompatibility of the composite is a prerequisite for BTE. Previous study 
has demonstrated that Gemosil has good biocompatibility.69 In the current study, we add 
co-solvent and CHX as additional components during the processing, and there is a 
possibility that the residual co-solvent and CHX could lead to cell toxicity. To investigate 
this possible pitfall, the following experiments were carried out. We chose THF/MeOH as 
the representative co-solvent/MeOH system and varied the amount of co-solvent and 
CHX as independent variables. Experimentally, four different types of composites made 
from (a) MeOH, Ca(OH)2, (b) MeOH, Ca(OH)2 CHX, (c) THF/MeOH, Ca(OH)2, (d) 
THF/MeOH, Ca(OH)2 CHX were incubated with cells. The viability of the potential 
transplanted cells in BTE application, rMSCs, was monitored by RealTime-GloTM MT 
cell viability assay. We used this method to distinguish the direct toxicity monitored by 
the cells attached to the composites and the leaching toxicity measured by the cells in the 
well surrounding the bulk materials. However, a quick screening showed poor cells 
attachment on bulk composite made from Ca(OH)2 with CHX and its surrounding area in 
the cell culture well, indicated acutely direct and leaching cytotoxicity resulting from 
CHX. We thus focused on comparing the cell toxicity of group (a) and group (c) to 
understand the impact of THF on cell viability. As shown in the Figure 2.3, the 
luminescent reading gradually increased from day 0 to day 1, suggesting the addition of 
THF during the composite processing did not decrease the cell viability compared with 
the non-toxic composite processed with MeOH only. The decreased luminescence on the 
day 2 may result from either the exhaustion of reagents or the confluency of cells on the 
composite. Importantly, we further discovered that when we replaced the Ca(OH)2 CHX 
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with just Ca(OH)2, the compressive strength of composites (with or without CHX) was 
comparable (Table A2.2 in Appendix). Therefore, we recommend to replace Ca(OH)2 
CHX with Ca(OH)2 for future use of the composites where good biocompatibility is 
required. 
 
Figure 2.3. Cell viability test by RealTime-GloTM MT cell viability assay (two way ANOVA 
analysis, P=0.0012). 
2.7 3D Porous Scaffold Fabrication and Mechanical Properties  
In addition to biocompatibility, other important considerations for scaffolds 
intended for BTE include the feasibility of forming porous structures yet still maintaining 
good mechanical strength. To this end, we fabricated 3D porous scaffold with the 
Gemosil (THF/MeOH) composite via the aid of computational topology design (CTD) and 
3D-printing. A good control on the porous architecture can be achieved (Figure 2.4 (a)). 
Moreover, porous scaffold processed with THF/MeOH has a compressive strength 
~11.33±1.25 MPa, increased by ~60% compared to the compressive strength of scaffold 
processed with MeOH (6.94±1.01 MPa) (Figure 2.4 (b)). This increment further proves 
the effect of co-solvent in improving mechanical strength of Gemosil composite. 
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Furthermore, the achieved compressive strength of scaffold processed with co-solvent is 
comparable to that (1-13 MPa) of the cancellous bone.13 All these indicate a great 
potential of such scaffold for BTE. Further in vivo test is in progress to access the 
feasibility of such scaffolds for biomedical applications. 
 
Figure 2.4. (a) Picture of the porous scaffold (pore size: 400 μm, porosity: 50%) and (b) 
compressive strength of porous scaffold processed with different co-solvents (student t-test, 
P=0.0001). 
2.8 Conclusion  
In conclusion, we successfully improved the mechanical strength of our previously 
developed Gemosil composite significantly with the aid of selected co-solvents (e.g., 
THF, CH3CN, THP, etc.). We further demonstrated that the improvement of mechanical 
strength was not due to chemical interaction/reaction between the different components in 
Gemosil and co-solvents. Instead, adding co-solvents helped the enTMOS network 
formation and the composite processing. As a result, the likely uniformly cross-linked 
enTMOS matrix and the more homogenous composite would result in higher mechanical 
strength. Moreover, we showed that the co-solvent/MeOH could be completely removed 
from the composite during the drying process, thus having minimum impact on the 
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biocompatibility of this new Gemosil composite. Finally, we demonstrated that porous 
scaffold processed with co-solvent can be easily made yet maintained good compressive 
strength. All these results point to that this newly modified Gemosil composite is a very 
promising candidate for BTE. Currently, we are focus on evaluating the effect of this new 
scaffold for bone regeneration in vivo.  
2.9 Experimental Section 
Materials 
HAp-Gel and Ca(OH)2 powder was prepared by the method reported previously.68 
Ca(OH)2 with CHX was prepared by doping 5%-10% CHX into Ca(OH)2 powder. 95% 
bis[3-(trimethoxysilyl)-propyl]ethylenediamine (enTMOS) and 62% enTMOS in MeOH 
were purchased from Gelest, Inc. (Morrisville, PA, USA). Solvents, including MeOH, 
EtOH, CH3CN, THF, tetrahydropyran (THP), DMSO, dimethoxyethane (DME), 1,4-
dioxane were purchased from Alfa Aesar and used as received. Ammonium persulfate 
(APS) was purchased from Sigma-Aldrich and used as received.  
Preparing the composite 
The method for making the composites was adapted from previous report.73 300 
mg HAp-Gel, 200 mg of Ca(OH)2 with CHX powder were transferred into a mortar and 
ground into fine powder. Then, the powder mixture was spread on a glass sheet, which 
placed on a cold stage to maintain a depressed temperature of - 20 °C. The pre-mixed 
enTMOS solution, including 360 μL of co-solvent, 200 μL MeOH and 500 μL 95% 
enTMOS, was then added into the powder mixture quickly and mixed continuously with a 
spatula for 30 seconds. Then, 80 μL 7.5 % APS in MeOH/water (v/v=3:7) was added to 
trigger the sol-gel reaction. After mixing thoroughly, the mixture was poured into a disk 
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mold (size: diameter: 15.58 mm and thickness: 2.8 mm, designed for 3-point bending 
test), which lay on a smooth glass slide. Another smooth glass slide was carefully covered 
at the top of the mold to remove extra material. This “sandwich” structure (glass slides at 
the top and the bottom, material in the disk mold in between) was clamped and sealed into 
a plastic bag for one week to let the composite dry slowly. Finally, the sample was further 
dried in an oven at 54 °C for 5 days before the flexural strength test. The reason why the 
temperature was set at 54 °C is because gelatin has been shown to degrade gradually around 
100°C and collagen has been shown to denature to gelatin between 60 °C and 80°C. Thus, 
we chose 54 °C to remove the remaining solvent as well as to avoid the degradation of gelatin or 
collagen. For comparison, composites without co-solvents, namely all MeOH, were also 
prepared according to the same procedure described above. Furthermore, previously 
reported Gemosil composite69 made from 62% enTMOS was also repeated here as a 
reference. Additionally, cylinder-shaped samples with a 1:2 ratio of diameter (3.8 mm) to 
length (7.6 mm) were made according to our previous report73 with the same composition 
described above. To prepare pure enTMOS network without HAp-Gel and Ca(OH)2 
CHX, APS was directly added to the pre-mixed enTMOS solution. After gelation, same 
drying process was applied as described above. 
Compressive and biaxial flexural test 
The testing procedures were performed according to methods established in our 
previous publication.72 Cylinder-shaped samples (3.8 mm diameter by 7.6 mm length) or 
disk shape samples (13 mm diameter by 2.5 mm thickness) were used for compression 
test and 3-point bending test, respectively. Mechanical testing was performed on an 
Instron machine (model 4411, Instron Co., Norwood, MA, USA) with a cross-head speed 
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of 0.5 mm/min. Same calculation method72 was used to get compressive strength and 
biaxial flexural strength. A minimum of three samples for each group were used in all 
mechanical testing.  
FT-IR 
Bulk composites were ground into fine powder. Then the fine powder was spread 
directly on diamond crystal and analyzed by Fourier-transform Infrared spectroscopy 
(FT-IR) using attenuated total reflection (ATR) mode.  
29Si solid state NMR 
29Si CPMAS NMR spectra were acquired on a Bruker DMX 360MHz WB NMR 
spectrometer operating at 71.55 MHz for 29Si and 360.13 MHz for 1H.  A Q8M8 (i.e. 
octakis(trimethylsiloxy)silsequioxane) sample was used to calibrate the proton pulse width and 
the silicon power level for the contact pulse (10ms).  A relaxation delay of 5 s and a sweep width 
of 27 kHz was used.  Total number of scans ranged from 4k to 16k.  Spectra were processed with 
50Hz line broadening and referenced to an external TMS sample. 
Morphology study 
For scanning electron microscopy (SEM) analysis, a sample was carefully cut from bulk 
disk-shaped composite. Then the sample cross-section was sputter-coated with gold in a vacuum 
and imaged using a Hitachi S-4700 Cold Cathode Field Emission SEM (Hitachi High 
Technologies America, Inc.). Energy-dispersive X-ray spectroscopy (EDS) analysis was 
performed to examine at different phase on sample’s cross-section, which were analyzed by Inca 
operator software. For transmission electron microscopy (TEM) analysis, the bulk composite 
was ground into a fine powder and suspended into MeOH with sonication. Then, a small drop 
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this solution was added to the TEM grid for imaging using a JEOL 2010F-FasTEM (JEOL USA, 
Inc.). 
3D porous scaffold fabrication 
A 3D cylindrical porous template (diameter: 5 mm and height: 10mm, pore size: 
400 μm, porosity: 50%) was designed using SolidWorks software (Dassault Systems 
SolidWorks Corp.,Waltham, MA, USA). This template (stl format) was then used to print 
a 3D wax mold made of Solidcape® Model (Solidscape Inc., Merrimack, NH, USA) with 
0.16 mm2 trusses and 0.16 mm2 pore sizes (continuous space) using a Solidscape 3D 
printer (Solidscape Inc., Merrimack, NH, USA). Next, the composite mixture was 
prepared on the cold stage as described above and injected to the 3D-printed mold before 
the materials was let to solidify. After setting for 3-5 minutes, the wax mold and the 
composite was immersed in acetone for 15 minutes to remove the wax template and 
release the 3D porous composite based scaffold, which is shown in Figure 2.4(a). The 
porous scaffold was air dried for one week, followed by drying at 52 °C for 4 days prior 
to the compression test. Same method and data analysis were used here to obtain the 
compressive strength. The compressive strength of the porous scaffold was averaged from 
at least three samples.  
Bulk material biocompatibility study via RealTime-GloTM MT cell viability assay  
Bulk disk samples (diameter: 6 mm, thickness: 1 mm) made from THF/MeOH or MeOH 
were leaching in H2O for 3 days, followed by gas sterilization and balanced in the cell growth 
media for overnight. The disk samples were then seeded with rat mesenchymal stem cells 
(rMSCs) in a Costar 48-well plate and incubated at 37 °C for overnight to allow cell to attach. 
Then the disk samples were transferred into a new 96-well opaque plate to prevent inter-well 
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interference during measurement, followed by addition of NanoLuc® luciferase and a cell-
permeant prosubstrate and incubated at 37 °C. At predetermined time points (i.e., 0 day, 1 day, 2 
days), the illuminance of each well with substrate was measured by Cytation 5 cell imaging 
multi-mode reader. Each group with minimum of three samples was tested for each time. The 
cell viability result was averaged from three separate measurements. 
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Chapter 3 CATECHOL-FUNCTIONALIZED ADHESIVE POLYMER FOR 
ENHANCING MECHANICAL STRENGTH OF SILANE-MODIFIED 
HYDROXYAPATITE-GELATIN COMPOSITE IN WET CONDITION  
3.1 Introduction  
In Chapter 2, we optimized the silane (i.e., enTMOS) sol-gel reaction condition through 
applying selective co-solvent during processing and were able to dramatically improve the 
mechanical strength of Gemosil composite (i.e., silane-modified HAp-Gel composite). For 
instance, the new Gemosil composite processed with THF as co-solvent, demonstrated almost 
twice the compressive strength (195 MPa vs. 97 MPa) and biaxial flexural strength (431 MPa vs. 
222 MPa) of the original Gemosil composite without THF, respectively. These findings offer 
valuable guidelines when selecting co-solvents to improve silane sol-gel processing and the 
mechanical strength of such composites. Moreover, the co-solvents can be completely removed 
during drying, thereby not compromising the biocompatibility of composite. Finally, we have 
shown that porous scaffolds could be easily fabricated, and such porous scaffolds demonstrated 
values of compressive strength around 11 MPa, comparable to those of cancellous bones.13 
However, there are challenges in using such porous scaffolds for bone regeneration in vivo. Our 
preliminary in-vitro degradation study showed that the scaffold degraded rapidly when immersed 
in water (H2O). Compressive strength of the porous scaffold decreased from 11 MPa to 0.5 MPa 
after it was immersed in H2O for 3 days. Therefore, our next goal was set to develop a more 
robust composite to be used as scaffolds for BTE application.
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One possible option is to incorporate a water-insoluble, biocompatible and cross-linkable 
polymer with sufficient mechanical strength into the composite, assuming the strength of such 
polymer networks was able to be carried into the composite. There have been numerous reports 
on blending polymers with various inorganic materials to improve the performance of the final 
composites, for instance, tuning their degradation profiles and increasing the toughness.54,82,83 
Given that biocompatibility and biodegradability are required for our application, we turned our 
attention to synthetic polymers with these features, such as poly (L-lactide acid)(PLLA),84,85 
poly(lactic-co-glycolic acid)(PLGA),86,87 polycaprolactone(PCL)88, and poly(trimethylene 
carbonate)(PTMC).89,90 These polymers have been long established as blends for a variety of 
medical applications due to their unique mechanical and degradation properties. Previously, our 
group designed a silane-functionalized P(LLA-co-PC) copolymer, aiming to enhance the long-
range interactions among different components in Gemosil by incorporating this copolymer 
within the Gemosil composite.72 In that study,72 this copolymer demonstrated several advantages. 
First, copolymerization of PLLA with PC lowered the glass transition temperature (Tg) of pure 
PLLA,91 which would help to ‘soften’ PLLA and provide better toughing effect to mitigate the 
brittle nature of the Gemosil composites.92 Second, the PC monomer allowed the incorporation 
of a pendant alkyne group for further post-functionalization. In the previous study, we 
functionalized the P(LLA-co-PC) copolymer with silane side groups on the PC unit; such silane-
functionalized P(LLA-co-PC) copolymers were designed to react with the enTMOS silane cross-
linker in the Gemosil composite during the sol-gel process, which would incorporate these 
copolymers into the Gemosil composite to further reinforce the composite.72 Indeed, we 
successfully increased the biaxial flexural strength of composite from 40 MPa to 60 MPa through 
the incorporation of this P(LLA-co-PC) polymer based network. Unfortunately, the compressive 
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strength of the polymer-incorporated composite greatly decreased (from 80 MPa to 30 MPa), 
likely due to the poor adhesion between the hydrophilic HAp-Gel and the hydrophobic polymers.  
To increase the adhesion between the aforementioned components, we decided to seek 
inspiration by searching nature’s methods of adhering biomaterials under aqueous conditions. A 
great example is mussels, which have demonstrated impressive adhesion to various substrates 
under wet conditions. These impressive adhesion properties are due to mussel adhesive proteins, 
which have several key structural features.93 For example, mussel adhesive proteins’ sequences 
have two main types of constituents, namely, catecholic amino acid (e.g., L-3,4-
dihydroxyphenylalanine (L-DOPA)), and amine-containing amino acids (e.g., lysine, histidine 
and arginine).93 Further studies revealed that the catechol groups in L-DOPA were able to form: 
a) adhesive interactions at the substrate surface through hydrogen bonding, π- π electron 
interaction and cation- π interaction,94,95 and b) a cross-linked network to improve cohesive 
strength through metal chelating95,96 or oxidative aryl-aryl coupling.97,98 All these contributed to 
mussel’s impressive adhesive properties. Moreover, amine group could provide a synergistic 
effect to mussel’s adhesion through ionic bonding to negatively charged surfaces 99 and 
intermolecular cross-linking with o-quinones through Michael addition or Schiff-base 
formation.95 Inspired by these findings, various synthetic polymers with catechol alone,97 or 
coupled together with amine 100 have been investigated to develop functional polymers with 
strong adhesive properties under wet condition.101 Among these, dopamine, perhaps the simplest 
molecule that covalently linking catechol and amine, has shown impressive adhesive and coating 
properties with its polymers.102 Recently, we introduced polydopamine (PDA) into our Gemosil 
composite, aiming to improve the adhesion between the hydrophilic HAp-Gel and the 
hydrophobic siloxane matrix. However, we observed limited improvement in compressive 
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strength, from 80 MPa to 100 MPa.73 This might be caused by the low molecular weight of 
PDA,103 which would not reproduce the long-range interaction of collagen in nature bones.  
These previous results motivated us to design a new polymer that could provide long-
range interactions as well as good adhesive properties. We envisioned a copolymer, P(LLA-co-
PC) decorated with cross-linkable adhesive catechol functional group (Scheme 3.1), would a 
potential candidate. We chose P(LLA-co-PC) as the parent polymer in order to introduce the 
favorable mechanical properties, biocompatibility and degradability, offered by P(LLA-co-PC). 
Moreover, the cross-linkable adhesive catechol functional group, newly added to P(LLA-co-PC) 
in our design, would provide two advantages. First, the interfacial adhesion between different 
components in the composite could be improved due to the impressive adhesive property of 
catechol; second, long-range interactions could be increased through the formation of polymer 
network via catechol aryl-aryl coupling between polymer and dopamine under oxidative 
condition. It should be mentioned that using dopamine small molecule together with catechol-
functionalized copolymer would further promote the network formation. It was expected that the 
combination of copolymer and dopamine would enhance the mechanical reinforcement effect 
compared to using copolymer only or dopamine only. In short, introducing of this newly 
designed cross-linkable adhesive polymer together with dopamine would likely help to mitigate 
the degradation issue by the presence of extra structural support from network and enhanced 
adhesion within composite, thereby improving the mechanical strength of composite under wet 
condition.  
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Scheme 3.1. Proposed polymer network formed through the catechol oxidative coupling between 
polymer and dopamine 
 
 
As shown in Scheme 3.1, we first synthesized P(LLA-co-PC) with pendant acetylene 
groups, following our previous report.72 A post-functionalization of the P(LLA-co-PC) with 
catechol functional groups through “thiol-yne” click chemistry, where the “yne” functionality 
comes from copolymer and “thiol” functionality was linked with catechol (i.e., catechol-4C-SH), 
offered the P(LLA-co-PC)(catechol). Having successfully prepared this new copolymer, we 
probed how the mechanical properties of our Gemosil composites would change upon 
incorporation of this copolymer and dopamine. A number of variables were investigated. From 
the copolymer point of view, we studied the ratio of catechol incorporation on the copolymer, the 
molecular weight of the copolymer; from the formulation point of view, we studied the ratio of 
copolymer vs. free dopamine in the composite. We found that with optimized polymer 
composition (catechol amount ~ 15%) and molecular weight (~16 kDa) as well as optimized 
copolymer and dopamine amount (i.e., 30 mg and 10 mg, respectively), the compressive strength 
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of scaffold could be improved by 20% under wet condition with the addition of the copolymer of 
and dopamine.   
3.2 Synthesis of Monomer and Cross-linker 
The synthesis of PC monomer, as shown in Scheme 3.2, was adapted from our previous 
report,72 and the targeted cross-linker molecule, 4-(4-mercaptobutyl) benzene-1,2-diol (i.e., 
Catechol-4C-SH), was prepared according to Scheme 3.3. Specifically, a Friedel-Crafts 
acylation of the commercially available 3,4-dimethoxybenzene, followed by a NaBH4 reduction, 
readily afforded the key intermediate (3.2’).104 This intermediate then went through a 
nucleophilic substitution of the bromide with the thioacetate to accomplish compound (3.3’). 
Treating compound (3.3’) with the strong Lewis acid BBr3 smoothly removed the methyl 
protecting groups, revealing the catechol group, which was then followed by the removal of 
acetate group to reveal the thiol group under acidic condition and afforded the target molecule 
(3.4’). The chemical structure of the product formed after each step was confirmed by 1H NMR 
(Appendix for Chapter 3).  
Scheme 3.2. Synthesis route of PC monomer 
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Scheme 3.3. Synthesis route of Catechol-4C-SH 
 
3.3 Synthesis of P(LLA-co-PC) Copolymers and Post-functionalization with Catechol  
The PLLA-co-PC copolymer was prepared according to our previous report.72 The 
successful synthesis of copolymer was characterized by 1H NMR spectra (Figure 3.1 and 
Appendix for Chapter 3). As demonstrated in our previous report,72 copolymers with different 
amount  of PC in the backbone, as shown in Table 3.1, could be readily obtained by varying the 
loading mol% of PC (0-50 mol%). We also observed that the number average molecular weight 
(Mn) of copolymer, characterized by gel permeation chromatography (GPC), gradually decreased 
with the increasing amount of loaded PC monomer (Figure A3.1 in Appendix). This was 
attributed to a faster consumption rate of LLA compared to PC during the copolymerization.72  
Table 3.1. Summarized polymerization data for P(LLA-co-PC) copolymers 
Entry PC loading 
(mol%) 
PC 
incorporation 
(mol%) 
Mn 
(kg/mol) 
Mw 
(kg/mol) 
Dispersity  
(Đ) 
1 16.7 11.7 16.4 22.4 1.36 
2 20 19.5 12.6 17.1 1.35 
3 30 24.0 9.3 12.7 1.36 
4 50 48.3 6.1 8.6 1.41 
5 100 100 4.2 4.7 1.13 
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Scheme 3.4. Synthesis of PLLA-co-PC copolymer functionalized with catechol through “thiol-
yne” click chemistry 
 
 
Having successfully obtained the P(LLA-co-PC) copolymer, we next attempted to 
functionalize the pendant acetylene of PC with catechol through “thiol-yne” click chemistry as 
shown in Scheme 3.4. “Thiol-yne” click chemistry 105 has been demonstrated as a powerful 
method for post-functionalization of polymers. Mechanistically, each yne moiety first reacts with 
one thiol functionality to form a vinyl sulfide (i.e., monoaddition product), followed by 
subsequent reaction of the vinyl sulfide with the second thiol to yield the 1,2-disubstitued adduct 
(i.e., bisaddition product).106 Interesting, according to previous report,107 for post-
functionalization of polymers with the “thiol-yne” method, one would need to have thiols in a 
large stoichiometric excess (usually 10 ×) to obtain close to 100% bisaddition product. In our 
case, we found under the stoichiometric (2 thiols:1 yne) condition, successful post-
functionalization of the copolymer with catechol were achieved, evidenced by the disappearance 
of pendant acetylene protons at δ=2.45 ppm and appearance of the phenyl protons at δ=6.56 ppm 
(associated with the phenyl ring of Catechol-4C-SH) in 1H NMR spectra (Figure 3.1). 
Additionally, through comparing the integrations of signals of phenyl protons (δ=6.56 ppm) with 
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lactide methane protons (δ=5.18 ppm) in 1H NMR spectra, we were able to calculate the 
incorporated catechol amount. We found that both monoaddition product and bisaddition product 
were obtained. For instance, when functionalizing P(LLA-co-PC)11.7% (i.e., entry 1 of Table 3.1, 
11.7 mol% of PC in the polymer backbone) with catechol, we found that the ratio of incorporated 
catechol to lactide in the polymer is around 14.3% (i.e., in average 1 yne reacted with 1.22 
thiols). Accordingly, we named the final copolymer as P(LLA-co-PC)11.7%(Catechol)14.3% for 
clarity.     
 
Figure 3.1. The 1H NMR spectra of homopolymers, copolymer and catechol functionalized 
copolymer. 
3.4 Optimization of Catechol Amount  
Previous studies have demonstrated that the amount of catechol on its functionalized 
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polymers can substantially influence the adhesive properties of catechol-bearing polymers. For 
instance, the Wilker group discovered that their mussel-mimic adhering copolymers, i.e. 
poly(3,4-dihydroxystyrene)-co-styrene, achieved the highest adhesive strength with the 
copolymer having an equivalent of ~ 33 mol% catechol.108,109 The authors believed this specific 
amount of incorporated catechol (33 mol%) would strike a balance between the cohesive and 
adhesive bonding; further increasing the catechol amount would likely cause too much 
crosslinking, causing the decrease of adhesive bonding to the surface. Given that our polymers 
also have catechol as the pendant group, similar to the polymer reported by the Wilker group, it 
would not be surprising that the amount of catechol in our copolymer would also have a strong 
impact on the adhesive property. Furthermore, since catechol has a much better solubility in 
common organic solvents than our copolymer backbone (i.e., P(LLA-co-PC)), the amount of 
incorporated catechol would also influence the solubility of the catechol-functionalized 
copolymer and related processability. In short, all these factors will exert influence on the 
mechanical strength of the final composite after the copolymer is introduced. Therefore, it is 
necessary to find the optimized amount of catechol incorporated with our copolymer.  
To examine the influence of the amount of incorporated catechol on the mechanical 
strength of the final composite, we prepared three polymers of varied amount of catechol. We 
chose to fix the loading molar ratio of yne:thiol to 1:2 to ensure similar click reaction efficiency 
(e.g., 1 yne would produce 1.22 pendant catechols, in average); this strategy allowed us to vary 
the amount of incorporated catechol by simply varying the amount of PC in the copolymer 
backbone. Specifically, in addition to PLLA-co-PC11.7% (entry 1 in Table 3.1), we also applied 
the thiol-yne chemistry to attach the catechol functionality to PLLA-co-PC19.5% (entry 2 in Table 
3.1) and PLLA-co-PC24% (entry 3 in Table 3.1), bearing 19.5 mol% and 24 mol% of PC 
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monomer in the copolymer backbone, respectively. The successful incorporation of catechol to 
each polymer was evidenced by the appearance of phenyl protons at δ= 6.56 ppm in 1H NMR 
spectra, which was associated with the original catechol-4C-SH (Appendix in Chapter 3). 
Similarly, through comparing the integration of signals from the phenyl protons at δ= 6.56 ppm 
and lactide methane protons at δ= 5.18 ppm, the amount of the incorporated catechol (mol%) 
was calculated (Table 3.2). Again, it was demonstrated that for all post-functionalization, both 
monoaddition and bisaddition product were obtained. Interestingly, for PLLA-co-PC24%, we 
obtained a higher click reaction efficiency (entry 3, Table 3.2, i.e., 1 yne would produce 1.5 
pendant catechols, in average), which could be caused by the lower molecular weight of PLLA-
co-PC24% and relative higher alkyne amount in polymer backbone. Unfortunately, copolymers 
with high amount of catechol, such as PLLA-co-PC19.5%-Catechol25% and PLLA-co-PC24%-
Catechol36%, were easily cross-linked in THF, likely due to the formation of hydrogen-bonding 
between catechol groups from different polymer chains. Such gels posed a significant challenge 
in further blending these catechol-functionalized copolymers into our composites; thus, we chose 
to fix the catechol amount around 15 mol% on the copolymer for our next investigation. This 
amount (15 mol%) would allow the maximum loading of catechol yet still maintain the solubility 
of such copolymer in common organic solvents. 
Table 3.2. P(LLA-co-PC) copolymers with different amount of catechol 
Entry PC incorporation (mol%) Catechol amount (mol%) Gelation behavior 
1 11.7 14.3 No 
2 19.5 25.0 Yes 
3 24.0 36.0 Yes 
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3.5 Optimization of the Molecular Weight of Copolymer 
After establishing the maximum allowable amount of catechol in the copolymer to be ~ 
15%, we next explored the impact of the molecular weight of catechol-functionalized copolymer 
on the mechanical strength of the final composite. The molecular weight can influence many key 
properties of polymers that influence mechanical strength, for example, the glass transition 
temperature (Tg), stiffness, strength, viscosity and toughness.110 We synthesized several 
copolymers with a variety of molecular weight by altering the monomer/initiator ratio during the 
polymerization. Please note that we attempted to fix the amount of incorporated catechol (i.e., 
optimized catechol amount ~15 mol%) in this series of copolymers through fixing the loading 
molar ratio of PLLA/PC at 85/15 during the polymerization. Based on the “thiol-yne” click 
reaction efficiency in our system discussed in Section 3.4, it is very likely to obtain ~15 mol% 
catechol incorporation in copolymer with 15 mol% of PC loading. Specifically, we varied the 
monomer/initiator molar ratio from 12.5 to 200 and four polymers with Mn ranging from 10.7 
kg/mol to 37.4 kg/mol were successfully obtained as shown in Table 3.3. Through similar “thiol-
yne” click chemistry, the four polymers prepared here displayed final catechol amount within a 
range of 13.9 -15.4 mol%. Representative 1H NMR spectra of P(LLA-co-PC)(Catechol) are 
provided in the Appendix for Chapter 3. 
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Table 3.3. P(LLA-co-PC)(Catechol) with different polymer molecular weight 
Entry Monomer/ 
Initiator 
molar ratio 
PC 
loading/incorporation 
(mol%) 
Catechol 
amount 
(mol%) 
Mn 
(kg/mol) 
Mw 
(kg/mol) 
Dispersity  
(Đ) 
1 12.5 15/11.7 14.3 10.7 12.3 1.15 
2 33.3 15/11.8 14.3 16.4 19.7 1.20 
3 100 15/12.2 13.9 24.3 34.5 1.42 
4 200 15/12.7 15.4 37.4 50.2 1.34 
 
We then blended each copolymer to our original composites (i.e. Gemosil, silane-
modified HAp-Gel composite) and measured the compressive strength and biaxial flexural 
strength of the final composite. We first used THF/MeOH (v/v=9:5), a mixed solvent system, to 
dissolve the copolymer, followed by blending the copolymer solution with HAp-Gel powder. 
There are two reasons for choosing this processing method. First, as shown in Chapter 2, 
THF/MeOH would likely promote the formation of a condensed structure of enTMOS silane 
network, offering good mechanical strength. Second, dissolving the copolymer in this mixed 
solvent would also provide a more homogenous mixing of copolymer with other components in 
the composites, such as HAp-Gel and enTMOS. After successfully forming new composites with 
the blended copolymer, we then carried out the mechanical testing to determine the effect of the 
molecular weight of our copolymers on the mechanical properties of the final composite. The 
results are compared in Figure 3.2. Interestingly, we find that the molecular weight of the 
copolymer does not seem to have a significant impact on the mechanical strength of the final 
composite, for both compressive strength and flexural strength. Nevertheless, the copolymer with 
a moderate molecular weight, around 16.4 kg/mol (entry 2 in Table 3.3), appeared to offer 
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slightly better mechanical performance of the final composite than others (Figure 3.2). Thus, we 
chose this particular molecular weight, i.e., P(LLA-co-PC)11.7%Catechol14.3% with a Mn of ~ 16.4 
kg/mol for further study.  
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Figure 3.2. Mechanical strength of composite processed with different molecular weight of 
P(LLA-co-PC)(Catechol).  
3.6 Optimization of Relative Amount of Catechol Functionalized Copolymer and 
Dopamine  
Having optimized the catechol incorporation amount and polymer molecular weight, the 
last part is to optimize the relative amount of catechol functionalized copolymer and dopamine. 
To further improve the internal adhesion within the composite, the mussel-inspired small 
molecule dopamine was incorporated to promote the network formation through participating in 
the oxidative catechol coupling during network formation. Since there are two variables here, 
i.e., the amount of dopamine and the amount of copolymer, we performed a statistical design and 
stimulation. Based on the statistical design of experiment, we tested the mechanical strength 
(both compressive strength and biaxial flexural strength) with various amount of dopamine and 
copolymer. The preliminary results are shown in Table 3.4. 
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Table 3.4. Mechanical strength of bulk composite with different amount of copolymer and 
dopamine 
Copolymer  
(mg) 
Dopamine  
(mg) 
Compressive strength 
(MPa) 
Biaxial Flexural 
strength (MPa) 
4.4 1.5 194.74 247.63 
4.4 8.5 158.21 239.43 
25.6 1.5 123.51 342.88 
25.6 8.5 145.69 524.56 
15 5 113.64 355.94 
15 5 107.35 306.82 
15 5 122.45 248.58 
15 5 122.78 258.98 
15 5 121.26 246.04 
15 5 186.90 378.39 
15 5 182.77 313.30 
15 10 144.79 428.72 
15 0 103.17 345.75 
 
With statistical stimulation, we displayed these results in Table 3.4 through a contour 
plot shown in Figure 3.3. For compressive strength, two maximum values (indicated by the red 
arrows in Figure 3.3(a)) were observed with all different combinations of copolymer and 
dopamine amount. One maximum value appeared at very low dopamine and copolymer amount, 
which can be explained by the fact that copolymer and dopamine haven’t exert their function due 
to the relative low amount. Interestingly, the compressive strength decreased as we further 
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increased the copolymer and dopamine amount. This could be ascribed to that the cross-linked 
network between copolymer and dopamine hasn’t formed yet. As a result, the copolymer and 
dopamine functioned as defects in the composite. As expected, with further increasing the 
copolymer and dopamine amount, the compressive strength of composite started to increase, 
which is attributed to the enhancing effect from the formation of copolymer and dopamine 
network in the composite. For the biaxial flexural strength (Figure 3.3(b)), a similar trend was 
observed. The highest biaxial flexural strength was achieved with high amount of copolymer and 
dopamine. Combining the stimulation results for both compressive and biaxial flexural strength, 
the optimized amount of copolymer and dopamine for achieving the largest enhancement of 
mechanical strength in composite was 30 mg and 10 mg, respectively.  
 
Figure 3.3. Contour plot for (a) compressive strength and (b) biaxial flexural strength of 
composite with various amount of copolymer/dopamine. 
3.7 Compressive Strength of Scaffold Under Wet Condition  
With the optimized catechol amount (~ 15%), polymer molecular weight (~ 16 kg/mol) 
and copolymer and dopamine amount (30 mg and 10 mg, respectively), we fabricated 3D porous 
scaffold (pore size: 400 μm and porosity: 50%) with copolymer/dopamine using the same 
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method described in Chapter 2 to see whether the formation of copolymer/dopamine network 
could help to mitigate the degradation of scaffold in H2O, thus improve the compressive strength 
of scaffold in wet condition (i.e. immersing the scaffold in H2O for 3 days before testing the 
compressive strength of scaffold). Scaffolds made with Gemosil and Gemussel (i.e., 
polydopamine-reinforced Gemosil) were also studied as references. As shown in Figure 3.4, 
Gemussel and Gemussel-polymer (i.e., Gemussel with copolymer) has demonstrated a 
compressive strength of ~1.9 MPa and ~2.3 MPa, respectively, which are increased by 1.7 and 
2.3 times compared to the compressive strength of Gemosil scaffold (~0.7 MPa). It should be 
mentioned that the incorporation of copolymer network into the Gemussel system could further 
improve the compressive strength of scaffold by 20%. This mechanical strength improvement 
allows this Gemussel-polymer system to be further studied in vivo to evaluate its performance for 
scaffold application. 
 
Figure 3.4. Compressive strength of scaffold under wet condition. 
3.8 Conclusion 
In summary, we have designed and synthesized a new biocompatible and biodegradable 
copolymer PLLA-co-PC with “cross-linkable” and adhesive catechol group. It has been 
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demonstrated that after incorporation of the copolymer together with dopamine into the 
previously developed Gemosil composite, the catechol-functionalized copolymer and dopamine 
together was capable of providing enhanced long-range interaction and improving the internal 
adhesion within the composite. Through optimizing the catechol incorporation amount, 
copolymer molecular weight and copolymer/dopamine amount, we were able to improve the 
compressive strength of the Gemosil scaffold significantly (from ~ 0.7 MPa to 2.3 MPa). 
Moreover, the incorporation of copolymer network into the Gemussel system could further 
improve the compressive strength of Gemussel scaffold by 20%. Our current focus is to 
investigate the cell toxicity of copolymer incorporated composite and further in vivo study.   
3.9 Experimental Section 
Materials 
1,1,1-Tris(hydroxyl methyl) ethane (THME, Aldrich, 99%), triethylamine (TEA, Aldrich, 
99%), 2,2-dimethoxy-2-phenylacetophenone (DMPA, Aldrich 99%), benzaldehyde (Aldrich, 
98%), p-toluene sulfonic acid (TsOH, Aldrich, 98.5%), tin(II) 2-ethyl hexanoate (SnOct2,98%, 
MP Biomedicals), and propargyl bromide (80% in toluene, TCI) were used as received. Ethyl 
chloroformate (99%) and CaH2 (60% in mineral oil), and 4-tert butyl benzyl alcohol (98%) were 
obtained from Acros Organics and used as received. 4-bromobutanoyl chloride and sodium 
borohydride (98%) was purchased from Alfa Aesar and used as received. Potassium thioaetate 
(98%) was obtained from Sigma Aldrich and used as received. L-Lactide was generously 
donated by Purac and used without further purification. N,N-bis [(3-
trimethoxysilyl)propyl]ethylene diamine (enTMOS, 95% in MeOH) was purchased from Gelest, 
Inc. and used as received. HAp-Gel and Ca(OH)2 powder was prepared by the method reported 
previously.68 Glutaraldehyde solution (50 wt.% in H2O) and glycine were purchased from Sigma 
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Aldrich and used as received. Hexanes, acetone, chloroform, dichloromethane (DCM), 
anhydrous toluene, anhydrous MeOH, ethyl acetate (EtOAc) and THF were obtained from 
Fisher. THF was freshly distilled over sodium before use.  
Synthesis of propargyl carbonate (PC) monomer 
Synthesis of PC monomer is adapted from previously reported work by Dyke et al.72 1H 
NMR (400 MHz, CDCl3): δ 1.11 (s, 3H), 2.46 (s, 1H), 3.49 (s, 2H), 4.07 (d, 2H), 4.17 (s, 2H), 
4.33 (d, 2H).  
Synthesis of catechol-4C-SH 
3.1’ and 3.2’ was synthesized according to previous literature report and their structure 
was evidenced by 1H NMR.104  3.1’: 1H NMR (400 MHz, CDCl3): δ 2.29 (m, J=6.8, 6.4Hz, 2H), 
3.13 (t, J=6.8 Hz, 2H), 3.54 (t, J=6.4 Hz, 2H), 3.93 (s, 3H), 3.94(s, 3H), 6.88(d, J=8.4 Hz, 1H), 
7.52 (d, J=2 Hz, 1H), 7.61(dd, J=8.4, 2 Hz, 1H). 3.2’: 1H NMR (400 MHz, CDCl3): δ 1.75 (m, 
J=7.6, 6.8 Hz, 2H), 1.88(m, J=7.2, 6.4 Hz, 2H), 2.58 (t, J=6.8, 6.4 Hz, 2H), 3.41 (t, J=7.6, 7.2 Hz, 
2H), 3.85 (s, 3H), 3.87 (s, 3H), 6.70 (s, 1H), 6.72(d, J=2 Hz, 1H), 6.78 (d, J=8.8 Hz, 1H). 
S-(4-(3,4-dimethoxyphenyl)butyl) ethanethoate (3.3’) compound 3.2’ (1.01g, 3.75 
mmol) was dissolved in anhydrous THF, then potassium thioacetate (0.64g, 5.63 mmol) was 
added and stir at R.T. for 1.5 h. Rotary evaporation was used to remove the THF, and the 
concentrated residue was dissolved in EtOAc and washed with water 3 times before drying with 
MgSO4 and concentrating again. Purification via a column using 4:1 hexane: EtOAc affords pure 
product as a yellow liquid (0.93g, yield: 92.3%). 1H NMR (400 MHz, CDCl3): δ 1.62 (m, 4H), 
2.32 (s, 3H), 2.57 (t, J=8 Hz, 2H), 2.89(t, J=8 Hz, 3H), 3.85(s, 3H), 3.87(s, 3H), 6.69(d, J=8Hz, 
1H), 6.71(d, J=4 Hz, 1H), 6.79(dd, J=8, 4 Hz, 1H). 
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Catechol-4C-SH (3.4’) compound 3.3’ (0.93g, 3.5 mmol) was dissolved in anhydrous 
DCM and degassed with argon for 15 minutes in an ice bath. 1M BBr3 in DCM solution was 
then added dropwise under argon. The reaction mixture was stirred for 2 hours before it was 
quenched with water slowly. After concentrating by rotary evaporation, the reaction mixture was 
dissolved in EtOAc and washed with water 3 times, then the organic phase was dried over 
MgSO4 and concentrated by rotary evaporation again. The crude product was then dissolved in 
1:1 v/v EtOH/12M HCl and heated to reflux for overnight to removal protection group to 
generate final product. The reaction mixture was concentrated by rotary evaporation again. The 
residue was subject to column chromatography using 1:1 hexane and EtOAc as the eluent to 
afford pure product as white solid (471mg, yield: 68%). 1H NMR (400 MHz, CDCl3): δ 1.33 (t, 
J=8 Hz, 1H), 1.63 (m, 4H), 2.52 (m, 4H), 6.59(dd, J=8,4 Hz, 1H), 6.69(d, J=4 Hz, 1H), 6.76 (d, 
J=8 Hz, 1H). 
Synthesis of copolymers by Sn(Oct)2 catalyzed ROP 
Polymerization was carried out based on previous reported.72 For all polymerizations, 
monomers/catalyst/initiator was fixed at 100/1/1. To synthesize copolymer with 16.7 mol% PC 
loading, first, under argon atmosphere, LLA (1.19g, 8.26 mmol) and PC (303 mg, 1.65 mmol) 
were added to a high pressure flask with 10 ml anhydrous toluene. Followed by adding Sn(Oct)2 
(stock solution in toluene:175.2 mM, 565 μL) and 4-tert-butylbenzyl alcohol (stock solution in 
toluene: 175.2 mM, 565 μL) quickly. The reaction container was then quickly transferred to a 
preheated oil bath (120 °C) for polymerization. The polymerization was then quenched with 
MeOH after 20 hours and the resulting copolymer was purified by precipitation into cold MeOH 
for 3 times. 1H NMR analysis indicated this polymer contain 11.7 mol% PC in the backbone and 
thus was denoted as P(LLA-co-PC)11.7% for clarity.  
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Post-functionalization of copolymer with catechol via click chemistry 
All post-functionalization through “thiol-yne” click chemistry was performed in 
anhydrous THF with UV light under argon atmosphere. A typical synthesis for functionalization 
of P(LLA-co-PC)11.7% with catechol-4C-SH is as follows: P(LLA-co-PC)11.7% (2 g, yne 
amount:1.183 mmol), catechol-4C-SH (466 mg, 2.366 mmol) and photoinitiator DMPA 
(606.75mg, 2.366 mmol) were loaded into flamed-dried 100 mL two neck round flask and 
dissolved with anhydrous THF under Argon atmosphere. After the reagents are totally dissolved, 
UV light was used to initiate the polymerization. After 2 hours, the reaction was quenched by 
adding small amount of MeOH. Catechol-functionalized copolymer was obtained by 
precipitating into cold MeOH to yield product as yellow powder. 1H NMR analysis indicated this 
polymer contain 14.3 mol% catechol in the backbone and thus was denoted as P(LLA-co-
PC)11.7%-Catechol14.3% for clarity.  
Characterization of polymers 
1H NMR was used to determine the monomer incorporation ratio. CDCl3 was used as the 
solvent. The molecular weight and polydispersity of the copolymers were determined by a 
Waters 1515 gel permeation chromatograph (GPC) using THF as the eluent as a flow rate of 1.0 
mL/min at 30 °C. A series of narrow polystyrene standards were used for the calibration of the 
columns.  
Fabrication of bulk composite with catechol-functionalized copolymer 
The method for making the composites was similar to the method described in the 
experimental section in Chapter 2. The processing method for additional copolymer and 
dopamine is dissolving them in THF/MeOH mixing solvent first and then mixing them 
with enTMOS to make a homogenous solution. This homogenous solution with 
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copolymer, dopamine and enTMOS was then added to HAp-Gel and Ca(OH)2 powder 
and made bulk cylinder and disk composite for compressive strength test and flexural 
strength test, respectively.  
Fabrication of porous scaffold with catechol-functionalized copolymer 
Porous template with pore size 400 um and porosity 50% was fabricated by 3D-
printing technique. Then polymer (25.6mg) and dopamine (8.5mg) was dissolved in 
THF/MeOH mixing solvent (v/v=9:5, total volume 280 μL) with 250 μL 95% enTMOS 
solution. The premixed stock solution was then added to HAp-Gel (150 mg) and Ca(OH)2 
(100 mg) powder and injected to the 3D-printed mold before the materials were left to 
solidify. Similar to the post-treatment process described in Chapter 2 experimental 
section, after setting for 3-5 minutes, the wax mold and the composite was immersed in 
acetone for 15 minutes to remove the wax template and release the 3D porous composite 
based scaffold. The porous scaffold was air dried for one week, followed by drying at 52 
°C for 4 days. Then scaffold was immersed in 5% glutaraldehyde solution for further 
cross-linking of gelatin and 5% glycine solution for 1 day to react with remaining 
glutaraldehyde before compression test.  
Compressive and biaxial flexural test 
The testing procedures were performed according to methods established in our 
previous publication.72,73 Cylinder-shaped samples (3.8 mm diameter by 7.6 mm length) 
or disk shape samples (13 mm diameter by 2.5 mm thickness) were used for compression 
test and 3-point bending test, respectively. Mechanical testing was performed on an 
Instron machine (model 4411, Instron Co., Norwood, MA, USA) with a cross-head speed 
of 0.5 mm/min. Same calculation method was used to get compressive strength and 
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biaxial flexural strength. A minimum of three samples for each group were used in all 
mechanical testing.  
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Chapter 4 INVESTIGATION OF DOPAMINE ANALOGUES: SYNTHESIS, 
MECHANISTIC UNDERSTANDING, AND STRUCTURE-PROPERTY 
RELATIONSHIP  
4.1 Introduction  
In our previously developed Gemussel composite, we introduced polydopamine(PDA) – 
a mussel adhesive proteins inspired material which has impressive adhesive property – to 
improve the internal adhesion between different components within composite. It was 
demonstrated that the incorporation of dopamine/PDA could effectively improve the mechanical 
strength of our composite. Even though dopamine/PDA has shown its application in our 
composite and many other areas, dopamine/PDA has its own limitations. For instance, PDA’s 
dark/black color is not favored for clinical applications and its polymerization mechanism is still 
elusive. In this chapter, dopamine and other catecholamines are studied more extensively to try 
to get a better understanding about dopamine polymerization mechanism and expand the scope 
of current mussel-inspire adhesive and coating materials for future applications.2 
Recently, the unique moisture-resistant adhesion of marine mussels has attracted 
scientists’ attention.101  Studies revealed that the mussel-adhesion is mediated by five unique 
adhesive proteins, all of which contain a significant amount of catechol-containing amino acid, 
L-3,4-dihydroxyphenylalanine (L-DOPA), and amine-containing amino acids, such as lysine, 
histidine and arginine.93 Unsurprisingly, fundamental understanding of the functions of these
                                                 
This chapter previously appeared as an article in Langmuir. Reprinted with permission from H. Hu, J. C. Dye, B. A. 
Bowman, C. C. Ko and W. You, Langmuir, 2016, 32(38), pp 9873-9882. Copyright (2016) American Chemical 
Society.  
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mussel adhesive proteins93,111 has facilitated the design of synthetic small molecules/polymers to 
mimic the unique adhesive property of mussels.97,112,113 Reciprocally, investigating these mussel 
protein-inspired small molecules/polymers, in particular, the structure-property relationship, has 
helped to identify the key functional components and the working mechanism for these unique 
adhesion/coating behaviors. Pioneering work by the Deming group114 demonstrated that the 
catechol functionality of L-DOPA is the primary component required to replicate the moisture-
resistant adhesion. Further studies have shown that catechol and its oxidized o-quinone form are 
largely responsible for the adhesive behavior through hydrogen bonding94,95 and cross-linking 
via metal chelating95,96 as well as aryl-aryl coupling,97,98 respectively.115 These discoveries have 
promoted the incorporation of catechol and its derivatives into various polymer backbones to 
achieve functional hydrogels and adhesives, among others. 97,109,112,116-119 
While the importance of having the catechol functional group to reproduce mussel’s 
adhesive properties has been generally agreed upon, the potential involvement of the amine 
group in achieving mussel’s adhesive properties is much less studied. Researchers suggested that 
the amine may contribute to the mussel’s adhesion via ionic bonding to negatively charged 
surfaces99,120 and intermolecular cross-linking with o-quinones through Michael addition or 
Schiff-base formation.95 Thus, having both catechol and amine would create a synergistic effect 
to reproduce the mussel’s adhesive properties.100 Indeed, in 2007, the Messersmith group first 
reported that dopamine, a small molecule that covalently links both catechol and amine, could 
form polydopamine (PDA) under mild conditions, e.g., under a buffer condition of pH = 8.5. 
More impressively, PDA demonstrated an almost universal adhesion/coating property to a variety 
of substrates, including metals, ceramics and polymers, among others. Inspired by the formation 
mechanism of the eumelanin polymer, Messersmith and co-workers proposed a similar 
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polymerization mechanism to explain the formation of PDA (Scheme 4.1). This proposed 
mechanism first involves the oxidation of dopamine to dopaminequinone, which can then cyclize 
to form dopaminechrome. Subsequent oxidation and rearrangement would form the pre-
monomer, which can then polymerize via oxidative coupling into the PDA.102 Though a 
generally agreed formation mechanism of PDA and its exact chemical structure remain 
elusive,121-124 the easy synthesis of PDA and its impressive coating/adhesive property have 
promoted the application of PDA and its derivative materials in various fields, including energy, 
environment and biomedical engineering.113  
However, PDA and its related materials have their own limitations. For instance, the dark 
brown/black color associated with PDA and its related materials102 are not desirable for certain 
clinical applications. Further structural functionalization of dopamine molecule without 
impacting its polymerization behavior also appears to be difficult; the only reported strategy to 
covalently incorporate dopamine with other polymers/organic materials is through its amine 
group, which, for example, can form amide with the pendent carboxylic acid from the parent 
polymer.118,119,125,126 This status quo motivated us to explore new mussel adhesive inspired 
molecules that could maintain notable features of dopamine/PDA, including water-solubility, 
facile polymerization, and the extraordinary coating ability, while mitigating issues in current 
systems.  
Based on all these previous studies, we hypothesized that any molecule that covalently 
links the catechol and primary amine functional groups would likely show similar 
polymerization and coating behavior as dopamine/PDA have demonstrated. However, the 
polymerization mechanism could be molecule dependent, in particular, when factoring in the 
proposed ring-formation process in the dopamine polymerization. In general, forming a cyclic 
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product from a linear precursor would be affected by both entropy and enthalpy. For example, in 
the series of dopamine analogues shown in Scheme 4.1, 3C-DA and 4C-DA would likely 
undergo cyclization during their polymerization, leading to the formation of cyclic structures 
(e.g., six-membered ring for 3C-DA) in their polymers, similar to the proposed five-membered 
ring formation in the case of dopamine (i.e., 2C-DA). This is because five- and six-membered 
rings are the most stable cyclics. Indeed, an earlier computational study of the intramolecular 
amine addition to ortho-quinones127 indicated the possibility of forming six- and seven-
membered rings. On the other hand, it is hard to imagine that 5C-DA and 12C-DA, having 
longer alkyl chains, would be able to undergo cyclization and form eight-membered ring (for 5C-
DA) and larger ring structure (for 12C-DA). This is because the large ring formation via 
intramolecular ring-closure is entropically unfavored. Therefore, having all these new dopamine 
analogues and investigating their polymerization behaviors would help shed more light on the 
polymerization mechanisms of dopamine and its analogues. Furthermore, comparing the 
adhesive and coating properties shown by these dopamine analogues would help to disclose how 
these subtle structural changes (i.e., the length of alkyl chain between the catechol and the 
amine) would influence the adhesive/coating ability of PDA and its derivative materials.  
Thus, the objective of our study is three-fold: synthesis, mechanistic investigation, and 
structure-property relationships. We find that all of these new dopamine analogues are able to 
polymerize, albeit likely via different mechanisms, based on experimental observations. While 
3C-DA and 4C-DA could go through similar polymerization pathways (e.g., cyclization followed 
by oxidative coupling) to the one proposed for dopamine (Scheme 4.1), 5C-DA and 12C-DA 
appear to go through a simpler reaction pathway to polymerize (e.g., without cyclization). 
Importantly, the adhesive properties of polymers from these dopamine analogues (including 
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dopamine) are tightly correlated with the amount of catechol and amine functionalities in the 
system, with negligible influence by the length of the alkyl chain that links catechol and amine. 
Furthermore, even the alkyl linkage between catechol and amine does not seem to be a 
prerequisite to achieve the adhesive property. In fact, non-covalently linked catechol and amine 
based molecular systems (e.g., catechol and “free” propyl amine) – when subjected to the same 
polymerization condition – also form materials that show comparable shear adhesive strength to 
those achieved with covalently linked catechol and amine via an alkyl chain. On the other hand, 
this covalent linkage via an alkyl chain seems to be critical in achieving the coating ability of 
these analogous catechol-amine systems: while the covalently linked catechol and amine systems 
also show comparable coating ability with their polymers to that of PDA, materials formed with 
un-linked catechol and amine only show mediocre coating abilities. 
Scheme 4.1. Overview of mussel-inspired materials and proposed polymer structure 
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4.2 Synthesis of Dopamine Analogues  
Due to the high reactivity of dopamine analogues that have unprotected amine and 
catechol groups, all these analogues were synthesized in their HCl salt form, similar to the 
commercially available dopamine (also as its HCl salt). Scheme 4.2 outlines the synthetic route 
that successfully offered the 3C-DA in its HCl salt form. A condensation of commercially 
available 3,4-dimethoxybenzaldehyde with cyanoacetic acid, followed by a NaBH4 reduction, 
leads to compound (4.3). Decarboxylation of (4.3) gives 3-(3,4-dimethoxyphenyl)propylnitrile 
(4.4), which undergoes another reduction by LiAlH4 to afford the key intermediate, 3-(3,4-
dimethoxyphenyl) propylamine (4.5).128 Multiple attempts to remove the methyl from the 
methoxy group (e.g., via BBr3 treatment) to directly convert (4.5) into the targeted 3C-DA failed, 
possibly due to the interference of the primary amine functionality of (4.5). Thus we decided to 
protect the primary amine with a trifluoroacetyl (Tfa) group, converting (4.5) into (4.6), 
following a similar protocol previously reported.129 Treating (4.6) with the strong Lewis acid 
BBr3 can then smoothly remove these two methyl groups, revealing the catechol of (4.7). In the 
last step, the Tfa protecting group is readily cleaved under strong acidic condition to generate the 
target molecule (3C-DA), however, in its HCl salt form (4.8). The chemical structure of the 
product formed after each step was confirmed by 1H NMR and 13C NMR spectra, respectively, 
and the chemical formula of target molecule (4.8) was further verified by ESI-MS. 
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Scheme 4.2. Synthesis route of 3C-DA Analogue 
 
The general synthesis of dopamine analogues (4C-DA, 5C-DA and 12C-DA) is largely 
similar to that of 3C-DA; the major difference lies in the preparation of 3-(3,4-
dimethoxyphenyl)alkylnitrile, molecule (4.4’) in Scheme 4.3. Specifically, a Friedel-Crafts 
acylation of the commercially available 3,4-dimethoxy benzene (4.1’), followed by a NaBH4 
reduction, readily affords (4.3’). A nuccleophilic substitution of the bromide in (4.3’) with the 
cyano offers (4.4’), which is the structural analogue to (4.4) in Scheme 4.2. The molecule (4.4’) 
can then to through similar reactions outlined in the Scheme 4.2 (i.e., from (4.4) to (4.8) to afford 
the targeted molecule (4.8’), also in its HCl salt form. 
Scheme 4.3. Synthesis route of 4C-DA, 5C-DA and 12C-DA Analogues 
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4.3 Polymerization Behavior Studied by UV-Vis Spectra 
After having obtained substantial quantity of these dopamine analogues (in their HCl 
form), we next explored their polymerization behavior with dopamine∙HCl as the 
control/reference. Given the difficulty in separating reaction intermediates from the 
polymerization, we chose to monitor the polymerization process by UV-Vis spectroscopy, which 
has been previously used to track the polymerization progress of dopamine.130,131 Though Tris 
buffer has been a popular medium for the polymerization of dopamine, we have noticed that Tris 
buffer could be incorporated into the PDA structure,122 which could interfere with our study on 
the polymerizations. Thus, we simplified the polymerization condition and carried out the 
polymerization of different dopamine analogues in aqueous solution with excess NaOH base.132 
Through comparing the time-dependent UV-Vis absorption spectra during the polymerization to 
the absorption feature of known reaction intermediates,116,130,131 we can identify plausible 
reaction pathways.  
Experimentally, after adding excess amount of base (dopamine analogue: 1M NaOH=1:8, 
molar ratio) to a dilute aqueous solution (1mM) of dopamine/3C-DA/4C-DA/5C-DA (NOTE: 
12C-DA is not soluble in water), UV-Vis absorbance spectra were recorded at different time 
intervals for 24 h. Figure 4.1(a) shows the time-dependent UV-Vis spectra of the polymerization 
of dopamine, which agrees well with a previous literature report.131 The most notable feature of 
the UV-Vis spectra is the appearance of an absorbance peak at 420 nm immediately after the 
base addition, which gradually develops its intensity in the first 25 min and then attenuates. As 
the polymerization progresses, this absorption peak broadens and gradually decreases; and the 
whole spectrum becomes almost featureless but widely absorptive after 4 h, which explains the 
black/brown color of polydopamine (PDA). Similar time-dependent UV-Vis spectra for the 
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polymerization of 3C-DA was observed (Figure 4.1(b)); however, the absorption peak position 
shifts to 470 nm, and the maximum peak intensity ever reached is much lower than that of the 
420 nm absorption peak observed in the dopamine polymerization. Nevertheless, the absorption 
spectrum loses this absorption peak (~ 470 nm) as the polymerization proceeds. More 
interestingly, the spectrum after 4 h does not bear much intensity after 450 nm, hence the 
solution containing poly(3C-DA) appears almost colorless (at low concentration) or much lighter 
color (at high concentration) than the solution of poly(2C-DA) (i.e., PDA). Interestingly, with 
one more methylene in its structure than 3C-DA, 4C-DA does not show any obvious absorption 
peaks during its polymerization, even at the very beginning (i.e., 2 min). This could be caused by 
a fast polymerization rate, which would render the observation of the reaction intermediate more 
difficult, given the “transient” nature of such reaction intermediate. Similar to 3C-DA, 4C-DA 
almost loses the absorption intensity entirely in the range of 400 nm to 600 nm during its 
polymerization (Figure 4.1(c)), whereas 5C-DA regains the absorption in the same region in the 
UV-Vis spectrum (Figure 4.1(d)). Finally, the polymerization of catechol and propylamine (i.e., 
the non-covalently linked molecular system of 3C-DA) also has noticeable absorption within the 
range of 400 nm to 600 nm (Figure 4.1(e)), though no clearly defined peak can be identified in 
the same range. Nevertheless, in all cases, the UV-Vis absorption spectrum becomes almost 
featureless after 24 h, with much less intensity in the visible region than that of the spectrum 
from the polymerization of dopamine.  
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Figure 4.1. Time dependent UV-Vis spectroscopy for the polymerization of dopamine analogues 
in aqueous solution after adding 1M NaOH. 
Given that alcohol-water mixed solvent has been used to affect the polymerization rate of 
dopamine133,134 and 12C-DA is insoluble in water but soluble in methanol (MeOH), we next 
chose methanol as the solvent to conduct the polymerization and aimed to spectroscopically 
capture the reaction intermediates. After adding the same excess amount of base (dopamine 
analogues: 1 M NaOH= 1:8, molar ratio) to a dilute MeOH solution (1 mM) of dopamine/3C-
DA/4C-DA/5C-DA/12-DA, we again monitored their polymerization by UV-vis (Figure 4.2). A 
few interesting observations can be noted. First, the noticeable absorption peak at 420 nm in the 
early stage of the dopamine polymerization in water (Figure 4.1(a)) loses its intensity for the 
same polymerization in the mixed solvent (Figure 4.2(a)), though a hump at 470 nm can still be 
identified in this broad absorption. Second, the UV-Vis spectrum for the 3C-DA polymerization 
in the mixed solvent (Figure 4.2(b)) is qualitatively similar to that in water (Figure 4.1(b)).  
However, the 470 nm peak has shown a higher intensity in the early stage of the polymerization 
and the time it takes for reaching the highest absorbance intensity is twice that as in water. 
Interestingly, the 4C-DA polymerization in the mixed solvent develops a new absorption peak 
around 480 nm, which eventually disappears after 24 h (Figure 4.2(c)). If we assume that the 
470 (480) nm absorption peak indicates the formation of the polymerization intermediate, a 
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shorter time to reach the maximum intensity and a faster disappearance of this absorption peak 
would imply more rapid formation of the polymer (Figure A4.1 and Figure A4.2 in Appendix). 
Under this assumption, it appears that the polymerization of either 3C-DA or 4C-DA in the 
mixed solvent (MeOH:water=125:1, v/v) is slower than the corresponding polymerization in 
water. Third, the dopamine analogues with longer aliphatic linkers (5C-DA and 2C-DA) show 
qualitatively similar time-dependence UV-Vis spectra (Figure 4.2(d) and 4.2(e)), with a 
noticeable absorption peak at 410 nm in the early stage of the polymerization. Nevertheless, in 
all these polymerizations of dopamine and its analogues in the mixed solvent, the UV-Vis spectra 
do not contain identifiable absorption peak beyond 350 nm after 24 h, similar to what were 
observed for the polymerizations in water. In contrast, the UV-vis spectra for the non-covalently 
linked catechol/propylamine has developed an absorption peak at 326 nm, whose intensity 
continues to rise even after 24 h (Figure 4.2(f)). Increasing the alkyl chain length for the non-
covalently linked system has negligible impact on the polymerization, evidenced by the fact that 
almost identical UV-Vis spectra were observed for catechol/dodecylamine (Figure A4.2g in 
Appendix). 
300 400 500 600 700
0
1
2
3
4
5 Dopamine (2C-DA)
(a)
A
b
s
o
rb
a
n
c
e
Wavelength (nm)
 
 
 no base
 5 min
 25 min
 50 min
 4 h
 24 h
300 400 500 600 700
0
1
2
3
4
5 3C-DA
(b)
 
 
 Wavelength (nm)
A
b
s
o
rb
a
n
c
e
 no base
 4 min
 10 min
 30 min
 4 h
 24 h
300 400 500 600 700
0
1
2
3
4
5 4C-DA
(c)
Wavelength (nm)
A
b
s
o
rb
a
n
c
e
 
 
 no base
 10 min
 20 min
 4 h
 24 h
 
 
66 
 
300 400 500 600 700
0
1
2
3
4
5 5C-DA
(d)
Wavelength (nm)
A
b
s
o
rb
a
n
c
e
 
 
 no base
 5 min
 15 min
 40min
 4 h
 24 h
300 400 500 600 700
0
1
2
3
4
5 12C-DA
(e)
Wavelength (nm)
A
b
s
o
rb
a
n
c
e
 
 
 no base
 4 min
 15 min
 35 min
 4 h
 24 h
 
Figure 4.2. Time dependent UV-Vis spectroscopy for dopamine analogues in MeOH (1mM) 
after adding 1M NaOH (MeOH:water=125:1, v/v). 
Combining our time-dependent UV-Vis data in both H2O and MeOH with literature 
reports on the polymerization mechanism of dopamine,121-124 we propose plausible mechanisms 
for the observed polymerizations as follows. First, the absorbance peak of ~470 nm (480 nm) 
(Figure 4.1(b), 4.2(b), 4.2(c)), appearing in the early stage of the polymerization of 3C-DA and 
4C-DA the early stage of the polymerization of 3C-DA and 4C-DA agrees well with the 
absorbance of dopachrome, which has been previously identified during the biosynthesis of 
eumelanin from L-DOPA and has a λmax of 473 nm.116  Therefore, we tentatively assign this 
peak to the formation of 3C-dopachrome and 4C-dopachrome (Scheme 4.4) via a similar 
formation process for dopachrome, i.e., intramolecular cyclization and then oxidation. On the 
other hand, for entropic reasons, it would be difficult for similar cyclization occurring during the 
polymerization of 5C-DA or 12C-DA, both having longer aliphatic chains between the catechol 
and the amine. Thus, we tentatively ascribe the 410 nm absorbance peak, which appeared during 
the 5C-DA and 12C-DA polymerization (Figure 4.2(d) and 4.2(e)) to the presence of 5C-
dopaquinone and 12C-dopaquinone (Scheme 4.4). In fact, this 410 nm peak agrees well with the 
~ 400 nm absorption peak for dopaquinone.98 In all cases (3C- to 12C-DA), the intensity of the 
absorption peak would decrease after a short period of time, because cross-coupling between the 
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structural units of catechol and/or quinone would increasingly dominate the reaction progress to 
form the polymer (Scheme A4.3 in Appendix). 
However, for dopamine polymerization, the UV-Vis spectrum is more complicated. First, 
in H2O/NaOH, we did not observe any absorbance peak at ~ 470 nm (Figure 4.1(a)), which was 
believed to indicate the formation of dopaminechrome, a known reaction intermediate for 
dopamine polymerization. This could be caused by the high pH (8 mM NaOH) and thereby rapid 
spectral evolution, which could mask the initial ~ 470 nm peak.135 Furthermore, we speculate the 
observed unique absorbance peak at ~ 420 nm (Figure 4.1(a)), which has also been observed by 
others,131 might indicate the formation of some oligomers (e.g., coupling of phenols) in the early 
stage of the dopamine polymerization. Interestingly, when we decreased the polymerization rate 
for dopamine polymerization with MeOH-H2O (v/v=125:1), we observed a broad absorption 
over the entire spectral range (Figure 4.2(a)) with a hump near 470 nm, which implies the 
formation of dopaminechrome. Nevertheless, the broad absorption which rendered the dark color 
of PDA, is believed to be a result of its complicated, presumably cross-linked structure 
analogous to that of eumelanin.102 It is very likely that PDA is a mixture of oligomers/polymers 
with various monomeric components (e.g., dopamine, dihydroxyindole, indoledione, etc.), tied 
together via cross-linking and non-covalent interactions.123,124 In contrast, the much lighter color 
of these new dopamine analogues after polymerization, supported by the much attenuated 
absorption in the visible region after 24 h (Figure 4.2(b) to 4.2(e)), suggests simpler structures 
that have less conjugation than PDA. Given the structural similarity between dopamine and these 
dopamine analogues, further investigation of the polymerization mechanism of these dopamine 
analogues – ideally, together with other dopamine analogues – can offer more insights on a 
clearer picture of the formation of PDA.  
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On the other hand, when the amine is not covalently linked with the catechol, the UV-Vis 
spectra of polymerizations with these molecular systems (i.e., catechol/propylamine and 
catechol/dodecylamine) are distinctly different from those observed with covalently linked ones 
(Figure A4.2(f) and Figure A4.2(g) in Appendix vs. Figure 4.2(a) to 4.2(e)). In particular, the 
absorption peak at 326 nm gains more intensity as polymerization continues and becomes much 
more visible after 24 h. We tentatively assign this absorbance peak at 326 nm to the Michael 
addition product between the quinone and amine or phenol coupling (Scheme 4.4). The 
polymerization of such non-covalently linked systems could undergo the coupling among 
semiquinone and/or quinones as well as products from Michael addition to form the polymers.136 
Lastly, please note that the proposed mechanisms are largely postulated based on the 
time-dependent UV-Vis absorption data for the studied molecular systems in the mixed solvent 
(MeOH:water = 125:1, v/v). The noticeable difference of UV-Vis spectra for the same molecular 
system in different solvents imply that the polymerization mechanism could also depend on the 
given solvent system, in particular, the water dominant system vs. the methanol dominant 
system. 
Scheme 4.4. Proposed reaction intermediates during polymerization 
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4.4 Adhesive Property Studied by Lap-shear Testing 
Many mussel-inspired materials have significant adhesive properties;102,109,112 since 
dopamine and the analogues in this study are also inspired by mussel, we next investigated the 
bulk adhesive properties of all molecular systems in our study. Specifically, we measured the lap 
shear adhesion of two glass substrates sandwiching the polymer, following a protocol established 
by the Wilker group.109 We first dissolved some monomers (including 2C-DA, 3C-DA, 4C-DA, 
5C-DA and catechol/propylamine) in water, or all monomers (2C-DA, 3C-DA, 4C-DA, 5C-DA, 
12C-DA, catechol/propylamine and catechol/dodecylamine) in isopropanol/water (1:2, v/v). 
Please note that isopropanol (IPA) was used here instead of methanol in order to further mitigate 
the solubility issue of 12C-DA. In fact, these two solvent systems appear to offer similar 
polymers via similar polymerization mechanisms for each studied molecular system, since UV-
Vis spectra for the polymerization in the mixed solvent where H2O was dominant (IPA-H2O, 
v/v=1:2) (Figure A4.3 in Appendix) are very comparable to those obtained in H2O (Figure A4.1 
in Appendix), for each studied molecular system. 
We then added excess base (100 µL 1M NaOH aqueous solution) to induce the 
polymerization. After 5 minutes, we applied 30 µL of the polymer solution onto one side of the 
glass slide, which was then covered with another identical glass slide with an overlapping area of 
1 inch × 1 inch. A binder clip was employed to maintain this sandwich structure for the next 48 
hours to ensure the completion of the polymerization (Figure 4.3(a), left). This binder clip was 
removed before the sandwich structure was tested via an Instron (Figure 4.3(a), right). After 
measuring three maximum load at break point for each polymer, adhesive strength was 
calculated by maximum load/sandwich area, i.e., 1 inch × 1 inch in our case. A load vs extension 
curve was obtained for each sample, which was qualitatively similar to literature 
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results109(Figure A4.8 in Appendix), indicating the complete removal of the solvent. In addition, 
we measured the UV-Vis spectra of the polymers sandwiched in between the glass substrates. 
The UV-Vis spectrum of the polymer does not contain characteristic absorption features of the 
reaction intermediate (for each studied system), and the overall spectrum is very similar to the 
final UV-Vis spectrum (i.e., measured after 24 h) of the same molecular system obtained in H2O. 
These results confirmed that it was the polymers that were tested in the lap shear testing (Figure 
A4.9 in Appendix). 
 
Figure 4.3.  (a) Image of test sample (left) and main part of Instron machine (right) for lap-shear 
testing; (b) results for adhesive strength for PDA, poly(3C-DA), poly(4C-DA), poly(5C-DA) and 
catechol/propylamine in water at 6.7 mg/mL;(c) results for adhesive strength for PDA, poly(3C-
DA), poly(4C-DA), poly(5C-DA), catechol/propylamine and catechol/dodecylamine in IPA: 
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H2O at 6.7 mg/mL (IPA:H2O=1:2, v/v); (d) results for adhesive strength for PDA, poly(3C-DA), 
poly(4C-DA), poly(5C-DA), catechol/propylamine and catechol/dodecylamine in IPA: H2O at 
33.3 mM (IPA:H2O=1:2, v/v). 
As shown in Figure 4.3(b), polydopamine (i.e., PDA), poly(3C-DA), poly(4C-DA) and 
poly(5C-DA) have demonstrated comparable adhesive strength (~ 90 kPa) from the identical 
polymerization in water (i.e., same mass concentration of 6.7 mg/mL), indicating that the 
increment of the aliphatic chain length between the amine and the catechol only negligibly 
influence the adhesive property of the polymer. Interestingly, the polymer from reacting 
catechol/propylamine under the same condition (i.e., catechol and propylamine together at 6.7 
mg/mL with 1:1 molar ratio) demonstrated almost identical adhesion strength as that of 
covalently-linked dopamine analogues, implying that the covalent bonding (i.e. the alkyl linkage) 
between the amine and the catechol is not necessary to achieve the adhesive strength of the 
polymer. 
Again, since 12C-DA is not soluble in water, we switched to the mixed solvent, 
IPA:water (1:2, v/v). For comparison with the results obtained with polymers synthesized in 
water, we used the same mass concentration (6.7 mg/mL) in the mixed solvent as well. 
Surprisingly, for each of dopamine and its analogues with longer aliphatic chains, the adhesive 
strength of the polymer created in the mixed solvent is significantly smaller than that of the 
counterpart synthesized in water. We offer two plausible explanations. First, the mixed solvent 
(IPA:H2O, v/v=1:2), which has a different solvent evaporation rate than that of pure H2O, might 
lead to incomplete film formation under our experimental condition. Alternatively, pure H2O 
may generate more polymers than the mixed solvent of IPA:H2O (though the structure of the 
polymers could be identical, regardless of the solvent system, as we previously discussed). 
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Furthermore, the adhesive strength of the polymer decreases monotonically from dopamine to 
12C-DA (Figure 4.3(c)). However, when the same polymerizations were done with an identical 
molar concentration (i.e., 33 mM) in the mixed solvent, the adhesive strength from the different 
polymers becomes comparable (Figure 4.3(d)), except the polymer from 12C-DA. We 
tentatively ascribe the weaker adhesive strength demonstrated by the polymer from 12C-DA in 
the mixed solvent to its limited solubility (even in the mixed solvent), which would significantly 
impede its polymerization. Nevertheless, these results indicate that the amount of catechol and 
amine in the system is proportional to the adhesive strength of polymers from these dopamine 
analogues in the mixed solvent. This conclusion is further supported by the fact that the polymers 
created from the non-covalently linked analogues (i.e., catechol/propylamine and 
catechol/dodecylamine) also show comparable adhesive strength to that of their covalently 
linked counterparts, when the same molar concentration (33 mM) was used for the 
polymerization in the mixed solvent (Figure 4.3(d)). This observation also supports the previous 
conclusion that the covalent bonding between the amine and the catechol is not a prerequisite for 
achieving the adhesive strength of the polymer. 
4.5 Coating Property Studied by XPS 
The most impressive property of polydopamine (PDA) is its ability to coat almost any 
substrates, effectively serving as an ad-layer to change the surface property of the coated 
substrate and allow further functionalization. Thus, our last task was to investigate the coating 
ability of these newly prepared polymers. To compare the coating ability of our newly 
synthesized dopamine analogues to that of PDA, we followed a protocol reported earlier by the 
Messersmith group, i.e.,10 mM Tris buffer, pH=8.5.102 To investigate whether the Tris buffer 
solution would have any impact to the polymerization when compared with the NaOH solution, 
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we conducted a similar time-dependence UV-Vis study of these dopamine analogs in the Tris 
buffer solution. Comparing the additional data (Figure A4.4 in Appendix) with the UV-Vis data 
acquired in H2O/NaOH (Figure A4.1 in Appendix), we did not discern any significant 
difference. Thus, we believe the polymerization mechanisms (and related polymers) in the Tris 
buffer condition would be comparable to those under the H2O/NaOH condition. 
We chose PTFE, which is known for its anti-fouling ability, as our target to study the 
coating ability of these polymers. Experimentally, PTFE substrate was immersed into dilute 
aqueous solutions of 3C-DA, 4C-DA, 5C-DA and catechol/propylamine, respectively (i.e., 2 
mg/mL in 10 mM Tris buffer, pH=8.5, following a protocol reported earlier by the Messersmith 
group),102 which were then gently stirred overnight. A control experiment with dopamine∙HCl 
was also carried out in parallel. The first observation is the noticeable coloration of the substrate 
after it was coated with the polymer (Figure 4.4(a)). While the PTFE substrate coated with PDA 
has a black brown/grey color in appearance, the ones coated with poly(3C-DA), poly(4C-DA) 
and poly (5C-DA) show lighter color instead. More importantly, X-ray photoelectron 
spectroscopy (XPS) characterization of the substrates coated with these dopamine analogues 
reveals a complete absence of the signals specific to the substrate (e.g., fluorine) after the 
coating, demonstrating a similar “shielding” effect as PDA has shown102 (Figure 4.4(a) and 
Figure A4.11 in Appendix). Further chemical analyses (via XPS) of the surface of these PTFE 
substrates after coating with these new polymers disclose that the nitrogen/carbon ratio is very 
close to the theoretical value of each dopamine analogue (Figure 4.4(b), rightmost column). This 
further supports a complete surface coating of the PTFE substrate by polymers from these 
dopamine analogues, similar to the coating ability of PDA.102 However, the non-covalently 
linked system, i.e., catechol and amine, is not able to achieve the complete coating of the PTFE 
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substrate, as the fluorine signal (from the PTFE substrate) is still present after the coating 
(Figure 4.4(a)). These results suggest that the covalent bonding between the amine and the 
catechol might play an important role to maximize the coating ability of these dopamine 
analogues. 
 
Figure 4.4. (a) XPS spectra of bare PTFE substrates, PDA coated PTFE and poly(3C-DA) 
coated PTFE, poly(4C-DA) coated PTFE, and poly(5C-DA) coated PTFE; (b) the quantitative 
analysis of nitrogen/carbon (N/C) ratio of different substrates coated with PDA and poly(3C-DA) 
as indicated by the black bar and red bar, respectively. Blue bar and green bar represent the N/C 
ratio of PTFE substrate coated with poly(4C-DA) and poly(5C-DA), respectively. 
To further investigate whether the excellent coating ability on PTFE demonstrated by 
these new dopamine analogues – similar to that of PDA – is also universal as PDA has shown,102 
we chose 3C-DA as the example to test the coating of its polymer on other substrates. For 
comparison, dopamine was also included in this set of experiments. Four different substrates 
having representative surface properties, gold, indium tin oxide (ITO), glass, and 
poly(ethyleneterephalate) (PET), were coated with poly(3C-DA) or PDA, following the same 
protocol as illustrated above. Not surprisingly, there is a visible change in the color appearance 
of the substrate after it was coated with the polymer (i.e., PDA or poly(3C-DA)) (Figure 
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A4.10(a) in Appendix). XPS characterization of the surface of these substrates after coating 
reveals a complete disappearance of substrate signals, demonstrating comparable coating ability 
of poly(3C-DA) to that of PDA (Figure A4.10(b) in Appendix). In addition, the nitrogen/carbon 
ratio, ranging from 0.902 to 0.972 on these coated substrates, is very close to the theoretical 
value of 3C-DA (0.1111) (Figure 4.4(b), red bar), suggesting a complete surface coverage on all 
these substrates by poly(3C-DA), similar to that achieved by PDA (Figure 4.4(b), black bar). 
These results strongly suggest that the 3C-DA, after polymerization, offers a similar coating 
ability and general applicability to those of dopamine/PDA. 
4.6 Conclusion 
In summary, through a series of molecular systems that are structurally analogous to 
dopamine, we demonstrate that the intriguing polymerization behaviors of dopamine are not 
unique to dopamine; in fact, it appears that all molecular systems that contain catechol and amine 
– covalently linked via an alkyl chain or not – are able to polymerize. However, the exact 
polymerization mechanism for individual molecular system appears to be dependent on (a) 
whether or not the catechol and amine are covalently linked via alkyl chain, and (b) the length of 
the alkyl chain that links the catechol and amine. Furthermore, the solvent system chosen to 
carry out the polymerization also seems to have an impact on the polymerization mechanism. It 
appears conditions where water is dominant (i.e., IPA:H2O, H2O and Tris buffer) should offer 
similar polymers via similar mechanism, whereas the polymerization mechanism in methanol is 
different. Further mechanistic studies on these molecular systems and other related systems are 
needed to elucidate the polymerization mechanisms.  
Furthermore, our results indicate that the covalent attachment of catechol and amine (e.g., 
as in the case of dopamine) appears to have only a negligible influence on the adhesive property 
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shown by polydopamine; almost all studied molecular systems show comparable adhesive 
strength when normalized with the amount of catechol and amine. However, such covalent 
linking between catechol and amine via an alkyl chain is crucial in reproducing the impressive 
coating ability that polydopamine has shown; noncovalently linked catechol and amine only 
show mediocre coating behaviors. All of these findings offer valuable guidelines in selecting and 
designing mussel adhesive protein-inspired materials for specific applications, including BTE 
application in the near future.  
4.7 Experimental Section 
The synthesis of 2-cyano-3-(3,4-dimethoxyphenyl)acrylic acid (4.1),128 2-cyano-3-(3,4-
dimethoxyphenyl)propionic acid (4.2),128 3-(3,4-dimethoxyphenyl) propanenitrile (4.4)128 and 3-
(3,4-dimethoxyphenyl) propylamine (4.5)137 were adapted from previous literature reports.  
2-cyano-3-(3,4-dimethoxyphenyl)acrylic acid (4.2) 3,4-dimethoxybenzaldehyde (15.00 
g, 89.78 mmol) and cyanoacetic acid (15.28g, 179.96 mmol) were dissolved in anhydrous 
toluene. Piperidine (17.78 mL, 179.96 mmol) was then added slowly to this reaction mixture and 
stirred under reflux for 17 hours. The reaction mixture was concentrated by rotary evaporation 
and the residue was dissolved in EtOAc and washed 3 times with 1 M HCl aqueous solution first 
and then washed with water 3 times. The organic phase was dried over anhydrous MgSO4 and 
concentrated by rotary evaporation to yield crude product 4.2 as a yellow solid. Purification 
through recrystallization in MeOH twice yielded pure product 4.2 as yellow needle-like crystals 
(16.75 g, yield: 80%). 1H NMR (400 MHz, CDCl3): δ 3.97 (s, 3H), 3.98 (s, 3H), 6.96 (d, J=8.5 
Hz, 1H), 7.50 (dd, J=8.5, 2.0 Hz, 1H), 7.85 (d, 1H, J=2.0 Hz), 8.22 (s, 1H). 
2-cyano-3-(3,4-dimethoxyphenyl)propionic acid (4.3) Compound 4.2 (5g, 21.43 mmol) 
was dissolved in THF and stirred at room temperature. NaBH4 (2.03g, 53.58 mmol) was then 
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added to this solution by portion and allowed to react for 15 hours. The reaction was quenched in 
an ice bath with dropwise addition of water and concentrated by rotary evaporation. The residue 
was then dissolved in EtOAc and washed with water three times before the organic layer was 
concentrated by rotary evaporation to afford product 4.3 as a white solid (4.54g, yield: 90%). 1H 
NMR (400MHz, d6-DMSO): δ 3.00 (dd, J=14 Hz, 8.8 Hz, 1H), 3.11 (dd, J=14, 5.2 Hz, 1H), 3.73 
(s, 6H), 4.26 (q, J=5.6 Hz, 1H), 6.80 (dd, J=8.4, 2 Hz, 1H), 6.88 (d, J=8.4 Hz, 1H), 6.91 (d, J=2.0 
Hz, 1H). 
3-(3,4-dimethoxyphenyl) propanenitrile (4.4) Compound 4.3 (4.54g, 19.28 mmol) was 
dissolved in DMF (30 mL) and refluxed for 12 hours. The solvent DMF was then removed by 
blowing with a gentle stream of air for a few hours.  The reaction mixture was then dissolved in 
EtOAc and washed with water 3 times. The organic phase was concentrated by rotary 
evaporation. The residue that contained the crude product was further purified by column 
chromatography using 2:1 hexane and ethyl acetate as the eluent to afford product 4.4 as a white 
solid (2.14 g, yield: 58%). 1H NMR (400MHz, CDCl3): δ 2.59 (t, J=7.2 Hz, 2H), 2.89 (t, J=7.2 
Hz, 2H), 3.86 (s, 3H), 3.87 (s, 3H), 6.74 (dd, J=8, 2 Hz, 1H), 6.77 (d, J=2 Hz, 1H), 6.82 (d, J=8 
Hz, 1H). 13C NMR (400MHz, CDCl3) δ 19.9, 31.5, 56.16, 56.19, 111.8, 111.8, 119.6, 120.6, 
130.9, 148.5, 149.3. 
Trifluoroacetyl (tfa) protected (4.5) (i.e., molecule 4.6) LiAlH4 (0.34g, 8.84 mmol) was 
dissolved in anhydrous THF and refluxed for 15 minutes. To this reflux solution, product 4.4 
(4.42 mmol, 0.85g) dissolved in anhydrous THF was added dropwise. After 2 hours, the reaction 
was cooled in an ice bath and quenched with saturated NaOH solution dropwise. After filtration 
to remove insoluble salts, the reaction mixture was concentrated by rotary evaporation to remove 
the THF, and the residue was dissolved in ethyl acetate and washed with water 3 times before the 
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organic phase was concentrated by rotary evaporation again to yield crude product 4.5 (3-(3,4-
dimethoxyphenyl) propylamine) as a white solid. Crude product 4.5 (0.55g, 2.82 mmol) was then 
dissolved in methanol and stirred at room temperature, followed by addition of methyl 
trifluoroacetate (0.31 mL, 3.10 mmol) and triethylamine (0.47 mL, 3.38mmol). After stirring 
overnight, the mixture was concentrated by rotary evaporation and then dissolved in EtOAc and 
washed 3 times with 1 N HCl followed by water, respectively. The organic phase was dried over 
MgSO4, and concentrated by rotary evaporation. The residue was subject to column 
chromatography using 2:1 hexane and EtOAc as the eluent to afford product 4.6 as a colorless 
liquid (0.40 g, yield: 31%). 1H NMR (400 MHz, CDCl3):  δ 1.92 (m, J=7.2 Hz, 2H), 2.65 (t, 
J=7.2 Hz, 2H), 3.40 (m, J=6.8 Hz, 2H), 3.86 (s, 3H), 3.88 (s, 3H), 6.26 (s, 1H), 6.71 (d, 1H), 6.73 
(s, 1H), 6.80 (d, J=8 Hz, 1H). 13C NMR (400MHz, CDCl3): δ 30.7, 32.9, 39.8, 56.0, 56.2, 111.7, 
111.9, 117.6, 120.4, 133.6, 147.8, 149.3, 157.6. 
Tfa protected 3C-DA (4.7) Compound 4.6 (0.40g, 1.37 mmol) was dissolved in DCM 
and degassed with argon for 15 minutes in an ice bath. 1 M BBr3 in DCM solution (5.48 mL) 
was then added dropwise under argon. The reaction mixture was stirred for 2 hours before it was 
quenched with water slowly. After concentrating by rotary evaporation, the reaction mixture was 
dissolved in EtOAc and washed with water 3 times, then the organic phase was dried over 
MgSO4 and concentrated by rotary evaporation again. The residue was subject to column 
chromatography using 1:1 hexane and EtOAc as the eluent to afford pure product 4.7 as a light 
yellow viscous liquid at room temperature (0.78g, yield: 85%). 1H NMR (400 MHz, CDCl3): δ 
1.85 (m, J=7.2, 6.8 Hz, 2H), 2.56 (t, J=7.2 Hz, 2H), 3.36 (m, J=6.8 Hz, 2H), 5.46 (s, 1H), 5.71 (s, 
1H), 6.34 (s, 1H), 6.59 (dd, J=8.4, 2 Hz, 1H), 6.69 (d, J=2Hz, 1H), 6.78 (d, J=8.4 Hz, 1H). 13C 
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NMR (100 MHz, d6-DMSO): δ 31.4, 32.9, 115.8, 116.7, 116.9, 118.7, 120.1, 133.3, 144.6, 
146.3, 157.4. 
3C-DA∙HCl (4.8) Compound 4.7 (0.31g, 1.16 mmol) was dissolved in 3N methanolic 
HCl solution (20 mL) and degassed with argon for 5 minutes before it was heated to reflux. The 
mixture was allowed to react overnight before it was concentrated by rotary evaporation to give a 
light yellow liquid. The crude product was then washed with ethyl acetate and ethyl ether three 
times, respectively, to generate the target 3C-DA∙HCl as a white solid (0.22g, yield: 92%). 1H 
NMR (400 MHz, d6-DMSO):  δ 1.76 (t, J=7.2 Hz, 2H), 2.44 (m, J=6.8 Hz, 2H), 2.71 (t, J=7.2, 
6.8 Hz, 2H), 6.42 (d, J=8.0 Hz, 1H), 6.58 (s, 1H), 6.64 (d, J=8.0 Hz, 1H), 8.00 (s, 3H), 8.72 (s, 
1H), 8.82 (s, 1H). 13C NMR (400MHz, d6-DMSO): δ 30.2, 32.5, 39.6, 116.8, 117.0, 120.1, 
132.8, 144.7, 146.4. HR-MS (LTQ FT-ICR MS) m/z: [M+] Calcd for C9H14NO2 168.1024; 
Found 168.1020. 
3-bromo-1-(3,4-dimethoxyphenyl)propan-1-one (4.2’, n=2) The synthesis of 4.2’ was 
adapted from previously reported literature.138 To a flame-dried 250 mL round bottle, 
AlCl3(19.35g, 145.13 mmol) in anhydrous DCM was added. After stirring for 5 minutes, 3-
bromopropyl chloride (12.4g, 72.33 mmol) was added into the mixture, followed by adding 1,2-
dimethoxybenzene (10.00g, 72.37 mmol) slowly. The reaction mixture was heated to reflux for 
1.5 h before it was quenched in an ice bath with H2O. After concentrating by rotary evaporation, 
the reaction mixture was dissolved in EtOAc and washed with water 3 times, then the organic 
phase was dried over MgSO4 and concentrated by rotary evaporation again. The residue was then 
subject to column chromatography using 4:1 hexane and EtOAc as the eluent. Recrystallization 
in mixed EtOAc and hexane twice affords pure product as a white crystal(7.12g, yield:37%). 1H 
NMR (400 MHz, CDCl3): δ 3.52 (t, J=7.2, 6.8 Hz, 2H), 3.72 (t, J=7.2, 6.8 Hz, 2H), 3.92 (s, 3H), 
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3.94(s, 3H), 6.88(d, J=8.4 Hz, 1H), 7.51 (d, J=2 Hz, 1H), 7.55(dd, J=8.4, 2 Hz, 1H). 13C NMR 
(400MHz, CDCl3): δ 26.5, 41.3, 56.3, 56.4,110.37, 110.39, 123.1, 129.9, 149.5, 154.0, 195.8. 
4-(3-bromopropyl)-1,2-dimethoxybenzene (4.3’, n=2) Sodium borohydride (1.47g, 
39.36 mmol) and alumina chloride (1.57g, 11.80 mmol) were added to a flame-dried two neck 
flask, then anhydrous THF was added as solvent. After stirring in an ice bath for 5 minutes, 
compound 4.2’ (n=2) (2.15g, 7.87 mmol) dissolved in anhydrous THF was added dropwise. The 
reaction mixture was then heated to reflux for 2 h before it was quenched with H2O slowly in an 
ice bath. Rotary evaporation was used to remove the THF, and the concentrated residue was 
dissolved in EtOAc and washed with H2O 3 times before drying with MgSO4 and concentrating 
again. Purification via a column using 4:1=hexane: EtOAc affords pure product as a colorless 
liquid (1.33g, 65.2%). 1H NMR (400 MHz, CDCl3): δ 2.14(m, J=7.2, 6.8 Hz, 2H), 2.73 (t, J=7.2 
Hz, 2H), 3.39(t, J=6.8 Hz, 2H), 3.86 (s, 3H), 3.88(s, 3H), 6.72 (s, 1H), 6.75 (d, J=1.6 Hz, 1H), 
6.80 (d, J=8 Hz, 1H). 13C NMR (400MHz, CDCl3): δ 33.5, 33.8, 34.6, 56.16, 56.24, 111.7, 
112.2, 120.7, 133.4, 147.8, 149.2.  
4-(3,4-dimethoxyphenyl)butanenitrile (4.4’, n=2) Compound 4.3’ (n=2) (878 mg, 3.36 
mmol) and NaCN (247 mg, 5.04 mmol) were dissolved in anhydrous DMF, the reaction mixture 
was heated to 90 °C and reacted for 4 h. Then H2O was added, and the reaction mixture was 
extracted with EtOAc for 3 times, the organic phase was dried with MgSO4, and concentrated 
through rotary evaporation. Purification via a column using 2:1=hexane: EtOAc gave pure 
product as a colorless liquid (660 mg, yield: 96%). 1H NMR (400 MHz, CDCl3): δ 1.96 (m, 
J=7.2, 6.8 Hz, 2H), 2.32 (t, J=7.2 Hz, 2H), 2.73(t, J=6.8 Hz, 2H), 3.86 (s, 3H), 3.88(s, 3H), 
6.71(dd, J=8, 2 Hz, 1H), 6.73 (d, J=2 Hz, 1H), 6.80 (d, J=8 Hz, 1H). 13C NMR (400MHz, 
CDCl3): δ 16.6, 27.4, 34.2, 56.17, 56.24, 111.7, 112.0, 119.9, 120.7, 132.6, 148.0, 149.4.  
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Trifluoroacetyl (tfa) protected 4 (i.e., compound 4.5’, n=2) Follow the same procedure 
for the synthesis of 3C-DA as described above. Starting with compound 4.4’(n=2) (660 mg, 3.22 
mmol) will afford final product as a colorless liquid (565 mg, yield: 57%). 1H NMR (400 MHz, 
CDCl3): δ 1.63(m, J=7.2, 6.8, 6.4 Hz, 4H), 2.60 (t, J=7.2,6.8 Hz, 2H), 3.38(q, J=6.8, 6.4 Hz, 2H), 
3.85 (s, 3H), 3.87 (s, 3H), 6.23 (s, 1H), 6.69 (s, 1H), 6.71 (d, J=2 Hz, 1H), 6.79 (d, J=7.6 Hz, 
1H). 13C NMR (400MHz, CDCl3): δ 28.8, 28.9, 35.2, 40.1, 56.2, 56.3, 111.7, 112.1, 117.5, 
120.5, 134.6, 147.9, 149.4, 157.8.  
Tfa protected 4C-DA (4.6’, n=2) Follow the same procedure for the synthesis of 3C-DA 
as described above. Starting with compound 4.5’ (n=2) (535mg, 1.75 mmol) will afford pure 
product as a light yellow liquid (415mg, yield: 86%). 1H NMR (400 MHz, d6-DMSO): δ 1.46 (t, 
J=3.6, 3.2 Hz, 4H), 2.38 (t, J=6.8, 6.4 Hz, 2H), 3.17 (b, 2H), 6.39 (dd, J=8, 2 Hz, 1H), 6.53 (d, 
J=2 Hz, 1H), 6.59 (d, J=8 Hz, 1H), 8.62 (b, 2H), 9.34 (b, 1H).13C NMR (400MHz, d6-DMSO): δ 
29.1, 29.5, 35.3, 40.2, 116.7, 116.9, 120.1, 134.0, 144.4, 146.2, 157.2.  
4C-DA∙HCl (4.7’, n=2) Follow the same procedure for 3C-DA∙HCl synthesis. Starting 
with compound 4.6’ (250 mg, 0.90 mmol) will give product as a white solid (179 mg, yield: 
91%). 1H NMR (400 MHz, d6-DMSO): δ 1.51(m, 4H), 2.38 (t, J=6.8, 6.4 Hz, 2H), 2.74 (b, 
J=6.8, 6.4 Hz, 2H), 6.41 (dd, J=8, 2 Hz, 1H), 6.56 (d, J=2 Hz, 1H), 6.62 (d, J=8 Hz, 1H), 7.88 (b, 
1H), 8.66(s, 1H), 8.73 (s, 1H). 13C NMR (400MHz, d6-DMSO): δ 27.8, 29.2, 35.2, 39.9, 116.8, 
117.1. 120.1, 133.7. 144.5, 146.3. HR-MS (LTQ FT-ICR MS) m/z: [M+] Calcd for C10H16NO2 
182.1171; Found 182.1176. 
4-bromo-1-(3,4-dimethoxyphenyl)butan-1-one (4.1’, n=3) Similar to the synthesis of 
compound 4.1’ (n=2): AlCl3(15.44g, 115.8 mmol) in anhydrous DCM was added to a flame-
dried flask which was cooled to 0 °C. After stirring for 5 minutes, 4-bromobutyl chloride 
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(10.74g, 57.9 mmol) was added into the mixture, followed by adding 1,2-dimethoxybenzene 
(8.00g, 57.9 mmol) slowly. Same to the reaction condition and post-reaction procedure for 
synthesizing 3-bromo-1-(3,4-dimethoxyphenyl)propan-1-one will afford the pure product as a 
light yellow crystal (7.8g, yield: 47%). 1H NMR (400 MHz, CDCl3): δ 2.29 (m, J=6.8, 6.4Hz, 
2H), 3.13 (t, J=6.8 Hz, 2H), 3.54 (t, J=6.4 Hz, 2H), 3.93 (s, 3H), 3.94(s, 3H), 6.88(d, J=8.4 Hz, 
1H), 7.52 (d, J=2 Hz, 1H), 7.61(dd, J=8.4, 2 Hz, 1H). 13C NMR (400MHz, CDCl3): δ 27.6, 34.1, 
36.4, 56.3, 56.4, 110.4, 110.4, 123.1, 130.4, 149.4, 153.8, 197.8.  
4-(4-bromobutyl)-1,2-dimethoxybenzene (4.2’, n=3) Similar to the synthesis of 
compound 4.2’ (n=2), sodium borohydride (1.46g, 38.8 mmol) and alumina chloride (1.55g, 
11.64 mmol) were added to a flame-dried two neck flask, then anhydrous THF was added as 
solvent. After stirring in an ice bath for 5 minutes, compound 4.1’ (n=3) (2.21g, 7.76 mmol) 
dissolved in anhydrous THF was added drop by drop. The reaction mixture was then heated to 
reflux for 2 h before it was quenched with H2O slowly in an ice bath. Following the same 
procedure for synthesizing compound 4.2’s (n=2) affords product also as a colorless liquid 
(1.67g, yield: 77%). 1H NMR (400 MHz, CDCl3): δ 1.75 (m, J=7.6, 6.8 Hz, 2H), 1.88(m, J=7.2, 
6.4 Hz, 2H), 2.58 (t, J=6.8, 6.4 Hz, 2H), 3.41 (t, J=7.6, 7.2 Hz, 2H), 3.85 (s, 3H), 3.87 (s, 3H), 
6.70 (s, 1H), 6.72(d, J=2 Hz, 1H), 6.78 (d, J=8.8 Hz, 1H). 13C NMR (400MHz, CDCl3): δ 30.2, 
32.5, 34.0, 34.8, 56.1, 56.2, 111.6, 112.0, 120.5, 134.7, 147.5, 149.2.  
5-(3,4-dimethoxyphenyl)pentanenitrile (4.3’, n=3) Same procedure to the synthesis of 
compound 4.3’ (n=2). Compound 4.2’ (n=3) (1.20g, 4.43 mmol) and NaCN (325 mg, 6.64 
mmol) were dissolved in 20 mL anhydrous DMF, the reaction mixture was heated to 90 °C and 
reacted for 4 h. Same post-reaction procedure with compound 4.3’ (n=2) affords product also as 
a colorless liquid (900 mg, yield: 93%). 1H NMR (400 MHz, CDCl3): δ 1.78(m, 2H), 1.68 (m, 
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2H), 2.35(t, J=7.2 Hz, 2H), 2.61(t, J=6.8 Hz, 2H), 3.86(s, 3H), 3.88(s, 3H), 6.69 (s, 1H), 6.71 (d, 
J=2 Hz, 1H), 6.79 (d, J=7.6 Hz, 1H). 13C NMR (400MHz, CDCl3): δ 17.4, 25.1, 30.7, 34.9, 
56.15, 56.23, 111.6, 111.9, 120.0, 120.5, 134.2, 147.7, 149.2.  
Trifluoroacetyl (tfa) protected 4 (i.e. compound 4.5’, n=3) Follow the same procedure 
for the synthesis of 3C-DA as described above. Starting with compound 4.4’(n=3) (685 mg, 3.39 
mmol) will afford final product as a colorless liquid (585 mg, yield: 54%).1H NMR (400 MHz, 
CDCl3): δ 1.38 (m, 2H), 1.63(m, 2H), 2.56 (t, J=7.6 Hz, 2H), 3.36 (q, J=6.8 Hz, 2H), 3.86 (s, 
3H), 3.87 (s, 3H), 6.27(s, 1H), 6.69 (s, 1H), 6.71 (d, J=2 Hz, 1H), 6.79 (d, J=8.4 Hz, 1H). 13C 
NMR (400MHz, CDCl3): δ 26.6, 29.2, 31.4, 35.6, 40.3, 56.2, 56.3, 111.6, 112.1, 117.8, 120.5, 
135.2, 147.8, 149.1, 157.4.  
Tfa protected 5C-DA (4.6’, n=3) Follow the same procedure for the synthesis of 3C-DA 
as described above. Starting with compound 4.5’ (n=3) (560mg, 1.75 mmol) will afford pure 
product as a light yellow viscous liquid (451 mg, yield: 89%). 1H NMR (400 MHz, d6-DMSO): 
δ 1.24 (m, 2H), 1.48(m, 4H), 2.36(t, J=7.6 Hz, 2H), 3.14(t, J=6.8 Hz, 2H), 6.39 (dd, J=7.6, 2 Hz, 
1H), 6.53 (d, J=2 Hz, 1H), 6.59 (d, J=7.6 Hz, 1H), 8.60 (b, 2H), 9.38 (b, 1H).13C NMR 
(400MHz, d6-DMSO): δ 27.0, 29.3, 32.0, 35.6, 116.6, 116.9, 118.8, 120.1, 134.2, 144.4, 146.2, 
157.4.  
5C-DA∙HCl (4.7’, n=3) Deprotection of Tfa protecting group by strong acid will give the 
targetted molecule in its HCl salt form. Follow the same procedure for 3C-DA∙HCl synthesis. 
Starting with compound 4.6’ (n=3) (250 mg, 0.86 mmol) will generate product as a white solid 
(169 mg, yield: 85%). 1H NMR (400 MHz, d6-DMSO): δ 1.28 (m, 2H), 1.48 (q, J=7.6 Hz, 2H), 
1.56 (q, J=7.6 Hz, 2H), 2.38 (t, J=7.6, 7.2 Hz, 2H), 2.73 (m, 2H), 6.41(dd, J=8, 2 Hz, 1H), 6.56 
(d, J=2 Hz, 1H), 6.62 (d, J=8 Hz, 1H), 7.90 (b, 3H), 8.63 (s, 1H), 8.72 (s, 1H).13C NMR 
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(400MHz, d6-DMSO): δ 26.7, 28.1, 31.9, 35.5, 39.9, 116.8, 117.1. 120.1, 134.0, 144.4, 146.2. 
HR-MS (LTQ FT-ICR MS) m/z: [M+] Calcd for C11H18NO2 196.1333; Found 196.1332. 
12-(3,4-dimethoxyphenyl)dodecanenitrile (4.3’, n=10) Start with 4-(11-
bromoundecyl)-1,2-dimethoxybenzene(4.2’, n=10) (1.6 g, 4.3 mmol) (which was synthesized 
according to previous literature report), then follow the same synthesis procedure of compound 
4.3’ (n=2) will give product as a colorless liquid (1.24g, yield: 91%). 1H NMR (400 MHz, 
CDCl3): δ 1.29 (m, 12H), 1.41(m, 2H), 1.58(m, 2H), 1.60(m, 2H), 2.31(t, J=7.2 Hz, 2H), 2.54 (t, 
J=8.0 Hz, 2H), 3.84 (s, 3H), 3.86 (s, 3H), 6.70 (d, J=2 Hz, 1H), 6.71 (d, J=2 Hz, 1H), 6.77 (dd, 
J=8.4, 2 Hz, 1H). 13C NMR (400MHz, CDCl3): δ 17.4, 25.6, 28.9, 29.0, 29.4, 29.6, 29.8, 32.0, 
35.8, 56.1, 56.2, 111.5, 112.1, 120.1, 120.4, 135.9, 147.3, 149.0.  
Trifluoroacetyl (tfa) protected 4 (i.e. compound 4.5’, n=10) Follow the same procedure 
for the synthesis of 3C-DA as described above. Starting with compound 4.4’(n=2) (354 mg, 1.11 
mmol) will afford final product as a white solid (215 mg, yield: 48%).1H NMR (400 MHz, 
CDCl3): δ 1.28 (m, 16H), 1.57 ((m, 4H), 2.54 (t, J=8.0 Hz, 2H), 3.35 (q, J=6.8 Hz, 2H), 3.85 (s, 
3H), 3.87 (s, 3H), 6.36(s, 1H), 6.70(d, J=2.0Hz,1H), 6.72(d, J=2.0Hz,1H), 6.78 (dd, J=8, 2Hz, 
1H). 13C NMR (400MHz, CDCl3): δ 27.0, 29.2, 29.4, 29.6, 29.8, 29.9, 32.0, 35.9, 40.4, 56.1, 
56.3, 111.6, 112.2, 117.7, 120.5, 136.0, 147.3, 149.1, 157.5. 
Tfa protected 12C-DA (4.6’, n=10) Follow the same procedure for the synthesis of 3C-
DA as described above. Starting with compound 4.5’ (n=10) (215mg, 0.54 mmol) will afford 
pure product as a white solid (202 mg, yield: 96%). 1H NMR (400 MHz, CDCl3): δ 1.24-1.29 (b, 
16H), 1.55 (m, 4H), 2.48 (t, J=7.6 Hz, 2H), 3.35(q, J=6.8 Hz, 2H), 5.30 (s, 1H), 5.44 (s, 1H), 
6.37 (s, 1H), 6.59 (dd, J=8.4, 2 Hz, 1H), 6.69 (d, J=2 Hz, 1H), 6.76 (d, J=8.4 Hz, 1H). 13C NMR 
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(400MHz, CDCl3): δ 27.4, 29.4, 29.8, 29.9, 30.17, 30.21, 30.3, 32.5, 35.8, 116.6, 116.9, 118.7, 
120.0 134.4, 114.3, 146.2, 157.3.  
12C-DA∙HCl (4.7’, n=10) Follow the same procedure for 3C-DA∙HCl synthesis. Starting 
with compound 4.6’ (n=10) (202 mg, 0.52mmol) will generate product as a white solid (150mg, 
yield: 87%). 1H NMR (400 MHz, d6-DMSO): δ 1.24 (b, 16H), 1.45(m, 2H), 1.52(m, 2H), 2.37 
(t, J=7.6 Hz, 2H), 2.74 (m, 2H), 6.39 (dd, J=8,2 Hz, 1H), 6.53 (d, J=2 Hz, 1H), 6.60 (d, J=8 Hz, 
1H), 7.99 (b, 3H), 8.60 (s, 1H), 8.68 (s, 1H).13C NMR (400MHz, d6-DMSO): δ 27.1, 28.2, 29.8, 
30.1, 30.2, 30.3, 32.5, 35.8, 116.7.117.0, 120.0, 134.3, 144.3, 146.2. HR-MS (LTQ FT-ICR MS) 
m/z: [M+] Calcd for C18H32NO2 294.2424; Found 294.2427. 
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Chapter 5 CONCLUSION AND FUTURE DIRECTION 
5.1 Conclusion   
In summary, an ideal scaffold is essential for successful BTE applications. Despite the 
fact that there are various scaffold materials, none of them are ideal. The primary goal of this 
dissertation was to further improve the properties of established Gemosil composite consisting of 
HAp-Gel with silane cross-linker, aiming to achieve a better material for BTE application. We 
have explored a few different approaches with various degree of success. In Chapter 2, we 
successfully doubled the mechanical strength of the Gemosil composite through developing a 
new processing method with the aid of selected co-solvents (e.g., THF, CH3CN, etc.). We further 
demonstrated that the improvement of mechanical strength was due to improved morphology of 
both silane network and composite. In Chapter 3, we designed and synthesized a biocompatible 
and biodegradable copolymer P(LLA-co-PC) with “cross-linkable” and adhesive catechol 
groups. We demonstrated that through incorporating this catechol-functionalized copolymer 
together with dopamine into our previously developed Gemosil scaffold, the compressive 
strength of scaffold in wet condition could be significantly improved due to the enhanced effect 
from the formed polymer network as well as improved internal adhesion. Moreover, the 
compressive strength of Gemussel scaffold (i.e., Gemosil with dopamine/polydopamine) was 
further improved by 20% under wet condition with the addition of this catechol-functionalized 
copolymer. In Chapter 4, we investigated the synthesis, polymerization behavior of dopamine 
analogues as well as the adhesive and coating properties of their polymers formed from these 
dopamine analogues. This study expanded the scope of current mussel-inspired adhesive and 
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Coating materials, thus providing more options for replacing dopamine in our composite for 
further improving composite properties, for instance, color issue. More importantly, it has 
offered new insights in the dopamine polymerization mechanism and better understanding of 
structure-property relationship. The exploration in this dissertation demonstrated that designing 
an ideal scaffold requires interdisciplinary efforts, involving chemistry, processing and 
fundamental understanding of mechanisms (e.g., network formation). Based on the results 
presented in this dissertation, we are able to identify several directions that could further improve 
the properties of the HAp-Gel based composite to serve as better scaffolds for BTE.  
5.2 Future Direction 
5.2.1 Exploring new polymers with better processability 
Our preliminary results in Chapter 3 indicated that the incorporation of catechol-
functionalized copolymer was capable of improving the compressive strength of Gemussel 
scaffold (i.e., Gemosil with dopamine/polydopamine) in wet condition through providing 
enhanced adhesion and long-range interactions within the composite. Nevertheless, the 
mechanical strength improvement was limited, only by 20%. We suspect that the main reason for 
the limited mechanical strength improvement is caused by the poor solubility of P(LLA-co-
PC)(Catechol) (Figure 5.1(a)) in the processing solvent, i.e. THF/MeOH mixed solvent (Note: 
P(LLA-co-PC) backbone is insoluble in MeOH). The limited solubility may result in an 
inhomogeneous distribution of copolymer in the composite and incomplete cross-linking of 
copolymer. To address this issue, future work will focus on designing new polymer with better 
solubility in current processing solvent (i.e. THF/MeOH). We plan to synthesize a new polymer 
as shown in Figure 5.1(b) with biocompatible polyethylene oxide (PEO) backbone and 
functionalizable ethylene side group.139 Since PEO has been shown to have a good solubility in 
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MeOH and many other organic solvents, we expect this new polymer would demonstrate a better 
solubility than P(LLA-co-PC)(Catechol) in THF/MeOH mixing solvent. Furthermore, the 
ethylene side group in the polymer backbone will allow post-functionalization with “cross-
linkable” and adhesive catechol group through “thiol-ene” click chemistry. Through 
incorporating this new polymer with catechol to our composite, we hope to further improve the 
mechanical strength of our current composite.  
 
Figure 5.1. Polymer design (a) old copolymer, and (b) new copolymer. 
5.2.2 Replacing dopamine with other catecholamines  
We have found that covalent-linkage of catechol and amine is not required for achieving 
good adhesive strength, we next plan to replace dopamine with non-covalent linked catechol and 
propylamine in our composite. This is because non-covalent linked catechol and propylamine are 
much cheaper than dopamine and they have better solubility in THF/MeOH mixing solvent 
(Note: commercial available dopamine is in the form of HCl salt, thus, it’s not soluble in THF 
solvent) (Figure 5.2 (a)). It is expected that non-covalent linked catechol and propylamine 
should be able to demonstrate comparable mechanical strength enhancement effect on the 
composite as dopamine has showed in our previous study. We further noticed that among the 
various dopamine analogues studied in Chapter 4, 3C-DA displayed a lighter color after 
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polymerization than dopamine; moreover, its polymer (i.e., P(3C-DA)) has demonstrate 
comparable adhesive and coating ability as PDA. Thus, we plan to use 3C-DA to replace 
dopamine for achieving lighter color of the scaffold, which could be desirable for specific 
applications (e.g., dental) (Figure 5.2(b)).  
 
Figure 5.2. Replace dopamine with (a) catechol/propylamine, and (b) 3C-DA. 
5.2.3 Exploring new materials: graphene oxide (GO)  
Finally, we have shown that imparting the polymer network strength into the composite 
could help to enhance the long-range interaction within the composite, thereby improving the 
mechanical strength of composite. Therefore, we envision that replacing the polymer network 
with materials that demonstrate better mechanical strength in composite would likely give further 
enhancement of the mechanical strength of our composite. We plan to use graphene to replace 
the polymer network. Graphene has been well-known for its impressive mechanical properties 
and good biocompatibility.140 Moreover, graphene can be easily oxidized to graphene oxide 
(GO), which bearing several functionalizable group, such as carboxyl and epoxy group.141 We 
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have successfully functionalized GO with cross-linkable silane or catechol group through the 
esterification reaction between carboxyl group in GO and amine group in (3-aminopropyl) 
trimethoxysilane or dopamine as shown in Figure 5.3. It will be interesting to incorporate this 
cross-linkable GO into our composite and investigate their effect on the mechanical strength of 
the composite.  
 
Figure 5.3. Silane or catechol functionalized GO as new materials for enhancing composite 
mechanical property.  
5.3 Concluding Remarks 
The efforts in synthetic bone scaffolds discussed in this dissertation are just a small 
component of the larger puzzle of BTE. Apart from the challenges in developing a sturdy 
scaffold with sufficient mechanical strength during whole bone regeneration process, exploring 
effective techniques to delivery biochemical factors and directing appropriate cell behavior in 
scaffold are also crucial for BTE, as briefly summarized in Chapter 1. Therefore, synergistic 
research efforts from materials scientists, biologists, engineers and medical doctors are required 
to continuously improve the BTE.  
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APPENDIX  
Appendix for Chapter 2  
Table A2.1. Mechanical strength for composites processed with co-solvents. 
 
Entry Co-solvent/MeOH Compressive 
strength (MPa) 
Biaxial flexural 
strength (MPa) 
1 62% enTMOS in 
MeOH 
143.11±27.27 141.88±20.19 
2 MeOH 97.09±20.3 222.83±54.80 
3 1,4-dioxane/MeOH 103.77±6.57 291.05±75.75 
4 THF/MeOH 195.24±1.98 437.94±49.95 
5 THF 72.23±12.40 152.14±19.69 
 
 
Figure A2.1. FT-IR spectra of Gemosil composite processed with different co-solvents. 
 
 
Table A2.2. Biaxial flexural strength for Gemosil composites with Ca(OH)2 and 
 Ca(OH)2 CHX. 
 
No Solvent Material Biaxial flexural strength 
(MPa) 
1 THF/MeOH Ca(OH)2 CHX 437.94±49.95 
2 THF/MeOH Ca(OH)2 420.67±44.54 
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Figure A2.2. Solid-state 29Si NMR of enTMOS silane network processed with  
different co-solvent. 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
Figure A2.3. EDS data of HAp-Gemosil: (a) one is enTMOS phase rich and (b) the  
other phase is HAp-Gel rich. 
b 
Element Weight% Atomic% 
C K 2.60 5.55 
O K 30.37 48.69 
Si K 2.50 2.28 
P K 11.56 9.57 
Ca K 52.97 33.90 
Total 100.00  
 
 
Element Weight% Atomic% 
C K  4.57 9.24 
O K 32.49 49.31 
Si K 7.16 6.19 
P K 5.96 4.67 
S K 1.73 1.31 
Cl K 1.77 1.21 
Ca K 46.33 28.07 
Total 100.00  
 
 
a 
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Figure A2.4. SEM images of Gemosil composite processed with a) MeOH, b) 
THF/MeOH(v/v=22.4), c)1,4-dioxane/MeOH (v/v=1.6). 
 
 
Figure A2.5. SEM images of pure enTMOS network processed with different co-solvents: a) 
MeOH, b)THF/MeOH (v/v=1.6), c)THF/MeOH (v/v=22.4), d) CH3CN/MeOH (v/v=1.6), e) 
CH3CN/MeOH (v/v=22.4). 
a b c 
a b 
c 
d 
e 
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Figure A2.6. TEM images of Gemosil composite processed with a) all methanol,  
b)THF/MeOH (v/v=1.6), c) THF/MeOH(v/v=22.4). 
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Appendix for Chapter 3  
1H and 13C NMR spectra  
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Figure A3.1. GPC curve for P(LLA-co-PC) with different PC loading.  
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Appendix for Chapter 4  
UV-Vis absorbance spectra in H2O 
 
  
 
300 400 500 600 700
0
1
2
3
4
5
0 60 120 180 240
0.0
0.4
0.8
1.2
1.6
 
 
A
b
s
o
rb
a
n
c
e
 a
t 
4
2
0
 n
m
Time (min)
 
 
(a)
A
b
s
o
rb
a
n
c
e
Wavelength (nm)
300 400 500 600 700
0
1
2
3
4
5
6
0 60 120 180 240
0.0
0.2
0.4
0.6
 
 
 
A
b
s
o
rb
a
n
c
e
 a
t 
4
6
5
 n
m
Time (min)
(b)
 
 
A
b
s
o
rb
a
n
c
e
Wavelength (nm)
300 400 500 600 700
0
1
2
3
4
5
0 60 120 180 240
0.05
0.10
0.15
0.20
 
 
 Time (min)
A
b
s
o
rb
a
n
c
e
 a
t 
4
7
0
 n
m
(c)
 
 
 Wavelength (nm)
A
b
s
o
rb
a
n
c
e
300 400 500 600 700
0
1
2
3
4
5
0 60 120 180 240
0.0
0.3
0.6
0.9
1.2
Time (min)
A
b
s
o
rb
a
n
c
e
 a
t 
4
0
5
 n
m
 
 (d)
Wavelength (nm)
A
b
s
o
rb
a
n
c
e
 
 
300 400 500 600 700
0
1
2
3
4
(e)
Wavelength (nm)
A
b
s
o
rb
a
n
c
e
 
 
 103 
Figure A4.1. Time dependent UV-Vis spectroscopy for (a) dopamine, (b) 3C-DA, (c) 4C-DA, 
(d) 5C-DA, and (e) catechol and propylamine aqueous solution after adding 1M NaOH. Inserted 
figure is the time-dependent change of characteristic absorbance peak. 
UV-Vis absorbance spectra in MeOH-H2O (v/v=125:1) 
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Figure A4.2. Time dependent UV-Vis spectroscopy for (a) dopamine, (b) 3C-DA, (c) 4C-DA, 
(d) 5C-DA, (e) 12C-DA, (f) catechol and propylamine and (g) catechol and dodecylamine in 
MeOH (1mM) after adding 1M NaOH. Inserted figure is the time-dependent change of 
characteristic absorbance peak. 
UV-Vis absorbance spectra in IPA-H2O (v/v=1:2) 
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Figure A4.3. Time dependent UV-Vis spectroscopy for (a) dopamine, (b) 3C-DA, (c) 4C-DA, 
(d) 5C-DA, (e) 12C-DA, (f) catechol and propylamine and (g) catechol and dodecylamine (1 
mM) in IPA: H2O, v/v=1:2, after adding 1M NaOH. Inserted figure is the time-dependent 
change of characteristic absorbance peak. 
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UV-Vis absorbance spectra in Tris buffer                                                                           
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Figure A4.4. Time dependent UV-Vis spectroscopy for (a) dopamine, (b) 3C-DA, (c) 4C-DA, 
(d) 5C-DA, and (e) catechol and propylamine (1 mM) in 10 mM Tris buffer (pH=8.5). Inserted 
figure is the time-dependent change of characteristic absorbance peak. 
 
Proposed polymerization mechanism for dopamine and dopamine analogues 
 
Scheme A4.1. Proposed polymerization mechanism for (a)dopamine (b)3C-DA and 4C-DA 
(c)5C-DA and 12C-DA (d) catechol and alkylamine 
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Adhesive strength result 
 
           
 
 
 
Figure A4.5. Histogram of load at break at same mass concentration in H2O for (a) PDA; (b) 
P(3C-DA);(c) P(4C-DA); (d) P(5C-DA); (e) Catechol and propylamine. 
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Figure A4.6. Histogram of load at break at same mass concentration in IPA-H2O for (a) PDA; 
(b) P(3C-DA);(c) P(4C-DA); (d) P(5C-DA); (e) P(12C-DA); (f) Catechol and propylamine; (g) 
Catechol and dodecylamine. 
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Figure A4.7. Histogram of load at break at same molar concentration in IPA-H2O for (a) PDA; 
(b) P(3C-DA);(c) P(4C-DA); (d) P(5C-DA); (e) P(12C-DA); (f) Catechol and propylamine; (g) 
Catechol and dodecylamine. 
 
Figure A4.8. Typical load vs extension curve for lap shear testing. 
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Figure A4.9. Normalized UV-Vis absorption spectra for (a) glass, (b) PDA, (c) P(3C-DA), (d) 
P(5C-DA), (e) Catechol and propylamine in H2O (solution) (i.e., UV-Vis spectra of polymers 
formed from monomers (1 mM) polymerized in H2O/NaOH after 24 h) and H2O (solid) (i.e., 
UV-Vis spectra of polymers between glass slides for lap-shear testing prepared from monomers 
(6.7 mg/mL) polymerized in H2O/NaOH). 
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Coating images and XPS result 
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Figure A4.10. (a) Visual image of different substrates with no coating, coated with PDA and 
P(3C-DA); (b) XPS spectra of bare substrates (left), PDA coated substrates (middle) and P(3C-
DA) coated substrates (right). 
 
 
Figure A4.11. XPS spectra of P(4C-DA) coated PTFE (left), P(5C-DA) coated PTFE (middle) 
and Catechol and propylamine coated PTFE(right). 
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1H and 13C NMR spectra  
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